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INTRODUCTION 
Lysosomes play a role in many normal and pathological cell functions. 
These include metamorphosis (226), rheumatoid arthritis (165), organelle 
turnover (67), fertilization (144) and storage diseases (97). The primary 
lysosome function is in the hydrolysis of denatured cellular components 
by a battery of specific, acid pH optimum, hydrolases contained within the 
membrane bound lumen of the lysosome. In the case of disease, such as 
rheumatoid arthritis and storage diseases, aberrations of this basic func­
tion are manifested. 
Storage diseases are genetic disorders in which there is an absence 
or lowered activity of specific lysosomal hydrolases that result in the 
accumulation of undigested substrates in the affected lysosomes. This 
accumulation leads to the swelling of the affected lysosomes, eventual 
rupture of the lysosomal membrane, and extensive damage leading to cell 
death. The study of lysosomal accumulation of Triton WR 1339 in rat 
hepatocytes is of interest because the process exhibits pathological 
characteristics similar to storage diseases and may serve as an experi­
mental model for the study of lysosomal storage diseases. 
The study of Triton WR 1339 effects on rat hepatocytes was begun in 
the 1940's (11,54). The bulk of the work involved biochemical studies of 
isolated Triton WR 1339 filled secondary lysosomes, although some parallel 
fine structural studies were performed. Essner and Novikoff (69) studied 
autophagic phenomena associated with Triton WR 1339 effects on rat hepato­
cytes. These studies involved time intervals up to four days post-
injection with Triton WR 1339. 
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This study was designed to investigate the subcellular changes that 
occur in rat hepatocytes following Triton WR 1339 treatment. Three 
parameters involved in these subcellular changes were chosen for examina­
tion: 1) morphological changes in hepatocytes following Triton WR 1339 
treatment, especially changes in lysosome morphology, packaging, distribu­
tion and clearance, 2) cytochemical distribution of acid hydrolase marker 
enzymes associated with lysosome function, and 3) biochemical changes in 
marker enzymes characteristically associated with those organelles in­
volved in hydrolase synthesis, packaging and lysosomal hydrolytic func­
tion. Information is presented from time intervals up to sixty days 
post-injection with Triton WR 1339. 
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LITERATURE REVIEW 
LysOSorne structure, function and packaging and Golgi apparatus 
structure and function have been reviewed in depth by deDuve and Wattiaux 
(53), Beams and Kessel (26), Morre et al. (143), Dingle and Fell (61,52), 
Dingle (58), Dingle and Dean (60) and Morre et al. (142), The goal of 
this review is to summarize the literature describing lysosome formation, 
function and induction in mammalian hepatocytes. 
The most lucid way to describe the lysosome-Golgi apparatus complex 
is in relation to the vacuome concept (50). The vacuome is an intra­
cellular system of membranous elements that separate some cellular materi­
als from the cytoplasmic matrix. The system consists of the outer nuclear 
envelope, the rough and smooth endoplasmic reticulum, the Golgi apparatus, 
secretory vesicles that carry materials between these structures, the 
outer mitochondrial membrane and the space between the outer and inner 
mitochondrial membranes. All of these elements have cisternal spaces that 
are separate from the cytoplasm. The elements of the vacuome are the same 
structures that are involved in Morre's endomembrane theory of membrane 
biosynthesis and differentiation (143). The vacuome has both anabolic and 
catabolic functions. 
The anabolic function of the vacuome involves the synthesis of pro­
tein and protein-containing molecules and the transport of some of these 
molecules to the cell surface. This process has been described for the 
exocrine pancreas by Jamieson and Palade (114-117) and Siekevitz et al. 
(188). Redman and Sabatini (174) have reported protein synthesis on 
ribosomes of the rough endoplasmic reticulum where the polypeptide chain 
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extends into the endoplasmic reticulum cisterne during synthesis. These 
polypeptide chains appear to contain special "signal" sections that are 
recognized by the endoplasmic reticulum which permits them to pass through 
the membrane into the cisternal space (29,30). From this point, the poly­
peptide chain moves through the cisternal space of the endoplasmic reticu-
ulum to the Golgi apparatus. The Golgi apparatus and parts of the endo­
plasmic reticulum add carbohydrates (110,148,149) and lipids (199) to the 
chain. From the Golgi apparatus, the proteins move away from the trans 
face (mature face) as Golgi vesicles which coalesce and condense to form 
zymogen granules or secretory vesicles that are transported to the cell 
surface and released by exocytosis. 
The catabolic function of the vacuonie includes the synthesis of 
hydrolytic enzymes, their packaging into lysosomes, fusion of the lysosome 
with endocytotic or autophagic vesicles, the digestion of the lumenal con­
tents and the extracellular release of the residual material. The synthe­
sis and transport of lysosomal enzymes to the Golgi apparatus follows the 
same pathway as other proteins. 
The nomenclature for the lysosomal system is confused; for the sake 
of clarity, the system described by Novikoff et al. (162) will be adopted: 
(a) Primary lysosome, a membrane-bound vesicle containing lysosomal 
hydrolases, but no substrate to be hydrolyzed. 
(b) Secondary lysosome, a membrane-bound vesicle containing lysosomal 
hydrolases and a substrate for them to hydrolyze. 
(c) Residual body, the remnants of a secondary lysosome following 
digestion of the substrate by lysosomal hydrolases. 
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(d) Autophagic vacuole, a membrane-bound vacuole containing cellular 
components. 
(e) Phagocytic vacuole, a membrane-bound vacuole containing extra­
cellular materials ingested by pinocytosis or phagocytosis. 
The structural elements of the vacuome interconnected by direct continuity 
or by discontinuous connections in the form of membrane-bound vesicles. 
Golgi Apparatus 
The Golgi apparatus was named for Camilo Golgi who first observed and 
described it in silver impregnated nerve cells (85). While the organelle 
is found in some form in most eukaryotic cells, the number per cell ranges 
from zero in some fungi to more than 25,000 in some algal rhizoids (32, 
189). Functionally, the Golgi apparatus is involved in synthesis and 
packaging of glycoproteins, mucopolysaccharides and glycolipids as well 
as membrane transport and differentiation (141,143). 
High voltage electron microscopic studies of osmium impregnated 
tissue show the Golgi apparatus as a series of interconnected structures 
scattered throughout the cell (173). The stacks of membranous saccules 
usually referred to as the Golgi apparatus may be called the dictyosome 
in some systems. There are usually 2 to 8 saccules in a dictyosome, al­
though there may be 30 or more in some lower organisms (230). The Golgi 
saccules may vary in form, but they all have a plate-like region and 
tubular elements with the exception of some fungi (75,138,139,142). The 
stacks of saccules or the dictyosomes are then interconnected to form the 
Golgi apparatus. The Golgi apparatus may vary from the extensive inter­
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connected system described by Rambourg et al. (173) in mammalian tissue to 
a single tubule in some of the fungi (33,36,137). 
The Golgi apparatus may be found in any part of the cytoplasm with 
the intracellular location depending on the functional state at any partic­
ular time. The-Golgi apparatus exhibits both morphological and functional 
polarity. The morphological polarity is demonstrated by the orientation 
of the mature face of the Golgi apparatus toward the cell surface. The 
cisternae of the Golgi apparatus also exhibit polarity within a single 
dictyosome. Grove et al. (90) have demonstrated differences in thickness 
of the membranes of the Golgi cisternae with the cisternae nearest the 
endoplasmic reticulum being the same thickness as the endoplasmic reticu­
lum, those nearest the plasma membrane being the same thickness as the 
plasma membrane; the center cisternae are intermediate between the two 
extremes. Functional polarity is demonstrated by the presence of a form­
ing face associated with the smooth endoplasmic reticulum and its transi­
tional elements and a mature face oriented toward the plasma membrane, 
associated with Golgi vesicles and secretory vesicles. The mature face of 
the Golgi apparatus is usually oriented toward the plasma membrane, but 
this is not always the case (18). Sainton and Farquhar (18) have reported 
changes in polarity of the Golgi apparatus during polymorphonuclear 
leukocyte development- At some stages, the mature face of the Golgi 
apparatus is oriented toward the cell surface and at other times toward 
the nucleus. 
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Structure and function 
While there may be no structural continuity between the Golgi 
apparatus and other structural elements of the vacuome, there is func­
tional continuity. The most convincing evidence for this continuity is 
derived fron the WDrk of Jamieson and Palade (114-117) and Caro and Palade 
(40) on the transport of secretory products through the exocrine pancreas 
cell. Using autoradiography, they demonstrated the pathway followed by 
secretory proteins from synthesis on the rough endoplasmic reticulum, into 
transitional vesicles, to the forming face of the Golgi apparatus and 
finally into zymogen granules. Warshawsky et al. (221) found evidence of 
carbohydrate addition to glycoproteins in the rough and smooth endoplasmic 
reticulum and in the Golgi apparatus. 
There is evidence of structural continuity between the Golgi appara­
tus and the endoplasmic reticulum (80) and between individual dictyosomes 
of the Golgi network (55,135). These connections are structures seen with 
the electron microscope and may not have functional significance. 
There are transitional structures that serve as connections between 
the Golgi apparatus and other organelles. Small membrane-bound vesicles 
arise in the region of the outer nuclear envelope and appear to move to 
the forming face of the Golgi apparatus (44,71,91,119). There may be 
direct connections or transitional elements serving as connections between 
the endoplasmic reticulum and the Golgi apparatus forming face (38,77). 
Essner and Novikoff (59) and Novikoff (153) have described the Golgi, 
endoplasmic reticulum, lysosome complex (GERL), a specialized region of 
the smooth endoplasmic reticulum that is associated with the mature face 
8 
of the Golgi apparatus. Evidence of continuity between smooth endoplasmic 
reticulum, Golgi apparatus and secretory vesicles have been demonstrated 
in algae (127), melanocytes (133) and hepatocytes (92,142). 
Connections between the Golgi apparatus and the plasma membrane are 
functional rather than physical. These connections occur through secre­
tory vesicles that are formed from the Golgi apparatus and later fuse with 
the plasma membrane (26,70,80,91,132,137,170,191). 
A transitional role of the Golgi apparatus as a connection between 
the endoplasmic reticulum and the plasma membrane has been proposed by 
several investigators (70,87,88,90,91,101,142,154,181,191,209,216). Grove 
et al. (90) demonstrated differences in thickness of the saccules within a 
single dictyosome, with the forming face being similar in thickness to the 
endoplasmic reticulum, the mature face similar in thickness to the plasma 
membrane and the central saccules of intermediate thickness. The struc­
tural evidence is not conclusive, primarily because of difficulty in 
measuring membrane thickness and demonstrating that thickness has not been 
altered during fixation and embedding. There are some differences in 
phospholipid and sterol contents which place the Golgi apparatus membranes 
in an intermediate position between the endoplasmic reticulum and the 
plasma membrane (118,232). The evidence strongly suggests that the Golgi 
apparatus has a role in membrane transformation. 
lysosOTie formati on 
The Golgi apparatus is a part of the vacuome that is involved in the 
synthesis and transport of glycoproteins. As most of the lysosomal 
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hydrolases are glycoproteins, the Golgi apparatus is of prime importance 
in the synthesis and packaging of lysosomal enzymes (25). 
Lysosomes 
The lysosome was first recognized at the turn of the century as a 
neutral red staining granule in the cytoplasm of Paramecium sp. by von 
Prowazek (217) and Nirenstein (151) who suggested that the structures 
might contain acid pH range enzymes. Nirenstein's concept of delivery of 
enzymes by the neutral red staining structures (151) and Volkonsky's con­
cept of progressive addition of enzymes to digestive vacuoles (212-215) 
gave rise to current ideas of lysosomal function. 
The earliest evidence of lysosome involvement in higher organisms 
comes from Metchnikoff's work on inflammation (135). Although the 
phenomenon of uptake of cellular and extracellular material by leukocytes 
had been observed by others, Metchnikoff was the first to propose the 
concept of phagocytosis (135). The confirmation of the cellular origin of 
the neutral red staining granules and their role in intracellular diges­
tion derived from the work of Hirsch and Cohn (102). 
Origin of the lysosome concept 
In 1949 deDuve and his co-workers began a series of studies on the 
intracellular location of a specific glucose-6-phosphatase, hexose phos­
phatase. As a control, they studied the intracellular distribution of acid 
phosphatase. During their studies, they found a tendency towards latency 
in the acid phosphatase activity. The acid phosphatase activity in water 
extracts was at least ten times that in samples homogenized in 0.25M 
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sucrose. Applemans et al. (11) suggested that this was due to a membrane 
surrounding the enzyme. Later studies pointed to the involvement of a new 
organelle that was morphologically distinct from mitochondria (54). 
Novikoff et al. (161) found a similar distribution of acid phosphatase, 
but did not consider the possibility of a separate group of structures. 
Walker found a similar distribution pattern for b-glucuronidase, and drew 
the same conclusions as deDuve about the mechanism of enzyme latency 
(200). 
The first electron microscopic evidence that lysosomes were distinct 
particles was published by Novikoff et al. (160). They found structures 
in pellets of centrifuged homogenates that resembled pericanalicular dense 
bodies (180). Later Straus (200,201) described particles from kidney 
tubules with similar characteristics. 
The modern definition of the lysosome 
At first the lysosome was regarded as a biochemical entity containing 
several acid pH range hydrolytic enzymes and exhibiting latency, but 
morphological evidence has led to changes in the definition. The modern 
definition of the lysosome involves three characteristics: (a) lysosomes 
contain several acid pH range hydrolytic enzymes and must exhibit latency 
for each enzyme, (b) lysosomes are sedimentable in density gradients, and 
(c) lysosomal enzymes can be localized in distinct, single-membrane limit­
ed structures (62). 
There are many different kinds of lysosomal activities, but they may 
all be classified as either autophagic or heterophagic. Autophagy is the 
digestion of intracellular material by a two step process. First, the 
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intracellular component is isolated in a membrane bound vacuole. Second, 
lysosomal hydrolases are added to the vacuole and the contents digested 
(60). One specialized type of autophagy is represented by crinophagy, the 
intracellular digestion of excess storage granules in endocrine and exo­
crine cells (60). Heterophagy is the intracellular digestion of materials 
of extracellular origin (60). The extracellular material enters the cell 
in pinocytic and phagocytic vesicles that subsequently fuse with lyso-
somes. 
Lys0some formation and morphology 
Primary lysosomes are apparently formed in two ways, by formation of 
vesicles at the mature face of the Golgi apparatus or by formation of 
regions of high concentration of hydrolytic enzymes in specialized parts 
of the smooth endoplasmic reticulum which in turn form vesicles containing 
the hydrolytic enzymes. 
The best evidence for primary lysosome formation at the mature face 
of the Golgi apparatus comes from the study of white blood cells. The 
azurophilic granules of neutrophils are lysosomes that are formed from 
vesicles which arise from the mature face of the Golgi apparatus and con­
dense and coalesce to form the granules (16-19,21,221). Eosinophils (12, 
20) and monocytes (150) form lysosomes in the same manner. In some 
cases, such as rat vas deferens epithelial cells, the Golgi vesicles them­
selves may be the primary lysosomes (19,21,80,152,158,228). Nichols et 
al. (150) have demonstrated a change in the pathway of primary lysosome 
formation as monocytes differentiate into macrophages. Monocyte primary 
lysosomes are large granules that are visible in the light microscope 
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while the lysosomes of macrophages are small vesicles. Both kinds of 
lysosomes arise from the Golgi apparatus, but in the macrophage they do 
not condense and coalesce into larger, more concentrated structures. 
Lysosomes arising from organelles other than the Golgi apparatus 
Lysosomes may arise from specialized sections of the endoplasmic 
reticulum (154) or by fusion of autophagic or heterophagic vacuoles with 
pre-existing secondary lysosomes. 
Golgi, endoplasmic reticulum, lysosome complex (6ERL) GERL is a 
specialized region of the smooth endoplasmic reticulum that has been de­
scribed in many tissues including rat basal ganglion neurons (106,153,162), 
hepatocytes (155), rat adrenal medulla (105) and b-16 Harding-Passey mouse 
melanoma (161). GERL is involved in the packaging of autophagic vacuoles 
and in the formation of residual bodies and coated vesicles (154). The 
autophagic vacuoles and residual bodies are secondary lysosomes, while the 
coated vesicles are primary lysosomes. 
Sarcoplasmic reticulum The sarcoplasmic reticulum of muscle cells 
appears to be the site of primary lysosome formation. The evidence is not 
definitive, but three lysosomal enzymes, B-glucuronidase, acid phosphatase 
and dipeptidyl diaminopeptidase II, have been localized in elements of the 
sarcoplasmic reticulum (104,111 and W. T. Stauber, University of Iowa, 
Iowa City, Iowa, personal communication, 1976). 
Secondary lysosomes Secondary lysosomes may arise from fusion of 
primary lysosomes or pre-existing secondary lysosomes with autophagic or 
heterophagic vacuoles. 
13 
Residual bodies The residual body is the end result of lysosome 
digestion. The material remaining in the residual body lysosome is 
apparently undigestible, but the hydrolytic enzymes of the lysosome are 
still active (53,132,166). The final disposition of the residual body may 
vary; apparently some residual bodies remain in the cell while others are 
removed by exocytosis. 
Lysosomal storage diseases 
A class of genetic diseases resulting from the absence of a single 
lysosomal enzyme are called storage diseases or lysosome storage diseases 
(98). Most lysosome storage diseases involve the inability of the cell to 
digest excess glycolipid or carbohydrate. Included in this group are Tay 
Sachs', Fabray's, Gaucher's and Nieman-Pick's diseases. Lysosomes normal­
ly digest excess quantities of many of the molecules synthesized by the 
cell. Storage disease pathology results from accumulation of undigested 
material in the lysosomes of affected cells. The lysosomes increase in 
size and number, eventually lysing and resulting in cell damage and 
possibly death. 
Lysosomotropic agents 
The concept of lysosomotropic agents was first introduced in the 
1970's (50,52). These agents are compounds that become sequestered in 
lysosomes if they are introduced to the cell. Most lysosomotropic agents 
are undigestible by normal cytoplasmic enzymes (50). Lysosomotropic 
agents are classified by their mode of entry into the cell. 
Permeation of the cell membrane Some molecules appear to be 
permeable to the cell membrane including neutral dyes [neutral red (9,11, 
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41,59,116,120,170,177), acridine orange (120,177,178) and brilliant cresyl 
blue (112)], chloroquine, the anti-malarial drug (4,7,11,72,231), and 
streptomycin (125,196,207). 
Basic dyes are absorbed by the cell and enter lysosomes resulting in 
increased autophagy, plasma membrane breakdown and damage to the lysosomal 
membrane in some cases (5,9,192). 
Chloroquine rapidly enters cells and is stored in cytoplasmic 
vacuoles of a lysosomal nature. The final concentration of chloroquine in 
the cell approaches the concentration in the medium (231). Recently 
Reijgould and Tager (175) have shown active uptake of chloroquine by iso­
lated lysosomes. Reijgould and Tager (175) and Homewood et al. (107) have 
demonstrated that the effect of chloroquine on malarial organisms is to 
change the pH of the malarial organism's food vacuole to a basic range and 
therefore prevent digestion of hemoglobin, which effectively starves the 
organism. Chloroquine-sensitive organisms seem to actively transport more 
chloroquine into their food vacuoles than resistant strains. 
Streptomycin is a naturally occurring lysosomotropic agent, but its 
optimum pH is much higher than the intra-lysosomal pH (125,196,207). 
Therefore, streptomycin is not effective against organisms living inside 
lysosomes. 
Endocytosis A number of lysosomotropic agents are taken up by 
endocytosis. Most of these compounds accumulate in phagocytic vacuoles 
that fuse with primary or secondary lysosomes. 
Enzymes Several cultured cell lines will absorb enzymes 
that are deficient in their lysosomes (15,42,45,56,99,100,147). Enzymes 
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taken up by endocytosis include invertase, B-glucuronidase and N-acetyl-B-
glucosaminidase. So far this phenomenon has not been of therapeutic use, 
but enzyme replacement of invertase has been reported in cases of artifi­
cially induced deficiency in rat liver (42), Cohn and Ehrenreich have 
demonstrated reversal of lysosomal sucrose loading in cultured macrophages 
following addition of invertase to the culture medium (45). Correction of 
genetic lysosomal enzyme defects by this mechanism has been demonstrated 
in several cases including deficiencies of a-L-iduronidase (15), B-glucu­
ronidase (99) and N-acetyl-B-glucosaminidase (99,100). 
Antibodies Antibodies enter lysosomes and there is evi­
dence that some antibodies are resistant to lysosomal enzymes (6,168). 
If antibodies to lysosomal extracts (6) or specific lysosomal enzymes 
(168) are used, the lysosomal activity of the cell may be inhibited 
(210). Fibroblasts treated with lysosomal hydrolase antibodies develop 
storage disease symptoms that suggest an inhibition of lysosomal enzyme 
activity (64). 
Polysaccharides Polysaccharides also accumulate in lysosomes 
of the liver, spleen and some other organs. These compounds include dex-
tran and acidic polymers of dextran sulfate (31,43,205,222) that increase 
the buoyant density of lysosomes. Carageenan (2) is another lysosomo­
tropic polysaccharide. 
Micrococcin Micrococcin is a compound of historical interest 
that is chemically related to Triton WR 1339. The compound is an anti­
biotic with a low biological activity, but it was used in the first 
attempts to target a lysosomotropic drug to a specific cell type (128-
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130). The failure of these experiments was probably due to the low activ­
ity of the micrococcin rather than failure of the drug to reach the 
target. 
Triton WR 1339 Triton WR 1339 is a nonionic detergent that 
rapidly enters lysosomes of several cell types, primarily liver and 
kidney (50), Triton WR 1339 has been used extensively in the isolation 
of lysosomes by density gradient centrifugation (208). Liver was used 
in most of the studies, but kidney, spleen (31) and muscle (39) will 
also absorb Triton WR 1339. The small amount that accumulates in the 
latter two tissues may be due to phagocytic cells in the tissue rather 
than muscle or spleen cells. 
Polyvinyl pyrrolidone Polyvinylpyrrolidone, which has been 
used as a plasma substitute, and polyvinylpyridine N-oxide are two lyso­
somotropic agents that have been used as slow release carriers of pitui­
tary hormones in the treatment of deficiency diseases such as diabetes 
insipidus (8,134). Both compounds are readily absorbed by cells, accumu­
late in lysosomes and cause storage disease pathology. 
Trypan blue and suramin Trypan blue and suramin are two 
lysosomotropic trypanicidal agents (46,146,171). Their mode of action may 
be inhibition of the trypanosome's lysosraues. 
Sucrose Sucrose is one of a number of smaller molecules that 
may act as lysosomotropic agents. During sucrose accumulation, lysosome 
diameter increases (34,45,63,145,163,222). The increase in lysosome size 
following treatment with lysosomotropic agents has led deDuve (50) to 
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propose that osmotic changes may be responsible for the increase in 
lysosome size. 
Piggyback endocytosis There are a number of compounds that can 
serve as carriers for materials entering lysoscmes. Most of the carriers 
are molecules that normally enter the cell by endocytosis, including anti­
bodies, nonantibody proteins, DNA, and dextran. Liposomes, structures 
formed by concentric layers of lipid, may trap materials in their lipid 
layers and carry the materials to the lysosomes. 
Antibodies There is no direct evidence of antibodies acting 
as carriers of molecules to lysosomes, but antibodies (50,81-83,140,136) 
and lectins (216) have been used as carriers of cytotoxic agents. The 
role of lysosome in processing these complexes is unknown. 
Nonantibody proteins Nonantibody proteins have been used as 
carriers of drugs to tumor cells (23,121,126,203,204,219), kidney (74), 
liver (55) and macrophages (24,27). Microbial diptheria toxin and two 
plant proteins, ricin and abrin, have been used as carriers (167). The 
latter three compounds are highly toxic and apparently enter the cell as 
two chains, one required for penetration of the cell membrane and the other 
having the cytotoxic properties. The two chains are separated in the 
cell, possible by lysosomal hydrolase action, and the toxic chain becomes 
active. Lysosomes are suspected of playing a role in the activity of 
other compounds entering the cell by attachment to protein carriers, but 
the lysosomal role in this activity has not been established (50). 
Deoxyribonucleic acid (DNA) Deoxyribonucleic acid (DNA) has 
been used as a carrier of two highly cytotoxic drugs, daunorubicin and 
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adriamycin (52,195,206). The TOIA-drug complexes are pinocytosed and enter 
lysosomes. Lysosomal DNAase digests the DMA carrier molecule and releases 
the active drug, which is resistant to lysosomal hydrolases. This tech­
nique has been used in the treatment of leukemia, because the DNA-drug 
complex is inactive and does not effect the cell until released by lyso­
somal hydrolases. 
Dextran has been used to carry iron to hepatocytes where the metal is 
slowly released (84,96). As dextran is a lysosomotropic agent, the 
dextran-iron complex is a good example of piggyback endocytosis. 
Liposomes have been used to carry enzymes (87-89), antibodies (224) 
and chelating agents (172) to lysosomes where the materials are released, 
probably by the action of lipases. 
Triton WR 1339 
Triton WR 1339 is one of the best known of the lysosomotropic agents, 
and it is the compound most commonly used to induce 1ysosome formation in 
rat hepatocytes. The most extensive use of Triton WR 1339 has been to 
change the buoyant density of lysosomes so they can be isolated by differ­
ential and density gradient centrifugation. Lysosomes in normal tissue 
have a sedimentation coefficient very similar to mitochondria and cannot 
be isolated in density gradients without altering their density. Triton 
WR 1339 has aided in the isolation of lysosomes from liver (224), visceral 
yolk sac epithelium (185), rat kidney (225) and a transplantable hepatoma 
(223). Leighton et al. (122) have reported the large-scale isolation of 
lysosomes, peroxisomes and mitochondria from rat hepatocytes treated with 
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Triton WR 1339. Other effects of Triton WR 1339 include changes in lipid 
storage and an increase in blood cholesterol (103). 
Wattiaux has suggested that circulating Triton WR 1339 becomes bound 
to a plasma a-1ipoprotein and enters the cell as a complex (222). He has 
also found evidence that iodinated Triton WR 1339 enters the cell in small 
membrane bound vesicles, but that it appears in secondary lysosomes by six 
hours post-injection. Wattiaux suggests that pinocytosis is the mechanism 
for Triton WR 1339 entry, but other authors (95,223) believe that both 
pinocytosis and diffusion are involved. 
Recently Henning and Plattner (93,94) found two fractions in commer­
cially prepared Triton WR 1339, a light and a heavy fraction, with the 
heavy fraction being the lysosomotropic agent. Triton WR 1339 apparently 
enters pre-existing lysosomes rather than new ones. This would be ex­
pected as secondary lysosomes are known to fuse with pinocytotic vesicles. 
Henning and Plattner (93,94) have also shown a two stage process in the 
formation of Triton WR 1339 filled secondary lysosomes. The sedimentation 
coefficient of hepatocyte lysosomes is 1.21 Svedberg units. After Triton 
WR 1339 treatment» the density of the lysosomes is altered to 1.13 Svedberg 
units and finally to 1.12 Svedberg units. The intermediate density lyso­
somes (1.13 units) are formed during the first few hours post-injection 
and gradually disappear with a concurrent increase in the 1.12 density 
lysosomes. This is probably due to fusion of lysosomes and changes in 
osmolality caused by the Triton WR 1339 entering the lysosomes. 
Alteration of the intralysosomal environment by Triton WR 1339 may 
account for the anti-tuberculosis activity of the compound (3). The 
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tuberculosis bacillus lives in the lysosome of the infected cell, and any 
change in the lysosome may have an effect on the bacillus. 
Schultz (183) and Schultz and Schultz (184) have demonstrated yolk 
sac changes and resorption followed by tetragenic changes in rat embryos 
following treatment of the mothers with Triton WR 1339. 
The importance of Triton WR 1339 lies in its lysosomotropic activity 
and the possibility of using this characteristic as a therapeutic aid in 
disease treatment or as a model system for the study of lysosomal storage 
diseases. 
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MATERIALS 
Male Sprague-Dawley rats weighing 250 to 300 grains were obtained from 
a breeding colony in the Department of Zoology, Iowa State University. 
Glutaraldehyde (70%) was purchased from Ladd Research Industries 
(Burlington, Vt.); osmium tetroxide from Electron Microscopy Sciences 
(Fort Washington, Pa.); propylene oxide, Epon Components, uranyl acetate, 
lead citrate and 2N phenol reagent from Fisher Chemical Company (Chicago, 
111.); Triton WR 1339 from Ruger Chemical Company (Irvington, N.J.); 
C^'* UDP-galactose and BioFluor from New England Nuclear (Boston, Mass.); 
cacodylic acid (Na salt), 1-2-4 aminotriazole, 3-3' diaminobenzidene, 
2-amino-2-methyl, 1-3 propandiol, p-nitrocatechol sulfate, B-glycerol-
phosphate, bovine serum albumin (Fraction V powder), Triton X-100, 
imidazole, hemoglobin, p-nitrophenyl sulfate, p-nitrophenyl-a-D-mannoside, 
B-glucuronidase assay kit, glùcose-6-phosphate (Na salt), and n-acetyl-
glucosamine from Sigma Chemical Ccrapany (St. Louis, Mo.); and 300 mesh 
copper grids and glass strips for knives from LKB Productor (Chicago, 
111). 
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METHODS 
Male Sprague-Dawley rats were injected once with 100 mg Triton WR1339 
in a 0.9% NaCl carrier/100 g body weight. At various times post-injection, 
animals were killed and the livers were removed. Samples from each liver 
were processed for morphological, cytochemical and biochemical evaluation. 
All solutions used in this study were made with doubly distilled water. 
Morphology 
Tissue samples for morphological examination were cut into 1 mm cubes 
and fixed for 2 to 3 hours at 4°C in a solution of 3% glutaraldehyde and 
3% sucrose dissolved in 0.1 M cacodylate buffer adjusted to pH 7.4. The 
cacodylate buffer consisted of the following components: 
0.1 M Na-cacodylate-HCl, pH 7.35 to 7.45 
10 mM CaClz 
If the buffer was used as a wash, the glutaraldehyde was omitted and an 
additional 3% sucrose was added. After fixation, the tissue blocks were 
washed overnight through several changes of 0.1 M cacodylate buffer. The 
blocks were then post-fixed for two hours in 1% osmium tetroxide dissolved 
in veronal acetate buffer (71,194). The buffer contained equal parts of 
the following components: 
0.05 M sodium acetate 
0.05 M sodium barbital 
0.039 M HCl 
The final pH of the buffer was 7.3 to 7.4; if 0.5% uranyl acetate was 
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added, the pH dropped to 5. The acid pH range was most effective for 
uranyl acetate staining. 
After staining, the blocks were dehydrated through graded ethanols 
and propylene oxide and embedded in Epon 812 (124). Sections with silver, 
silver-grey or grey interference colors were cut with glass or tungsten-
coated glass knives (179) on a LKB Ultrotome III ultramicrotome, post-
stained with uranyl acetate and lead citrate (78,176) and examined on a 
Hitachi HU-ll-E electron microscope operated at 50KV with a 200 um con­
denser aperture and a 30 um objective aperture. 
Cytochemistry 
Tissue blocks were fixed in glutaraldehyde and rinsed overnight in 
cacodylate wash buffer. Sections (25 um) of fixed tissue were cut on a 
Sorvall TC-2 tissue sectioner and collected in cacodylate wash buffer 
(193). Three cytochemical enzyme localizations were used: B-glycerol-
phosphatase and aryl sulfatase for lysosomes and catalase for peroxisomes. 
It vas important to use fresh reagents, especially lead nitrate, through­
out these studies. 
B-qlycerolphosphatase (acid phosphatase) 
B-glycerolphosphatase activity was localized by a modification of the 
method of Wachstein and Meisel (218). The pH of the incubation medium was 
lowered to 5.0 and B-glycerolphosphate was used as a substrate. The incu­
bation medium consisted of the following components; 
20 ml of 0.125% B-glycerolphosphate 
20 ml 0.2 M Tris-maleate buffer, pH 5.0 
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5 ml 0.1 M MgCla 
3 ml 1% PbNOs (fresh) 
2 ml doubly distilled water 
The tissue was incubated for 30 minutes at 37®C. Two parallel controls, 
substrateless and 0.1 M NaF inhibited, were run for each localization. 
The reaction depended on the liberation of an end product which combined 
with lead ion to form an insoluble precipitate: 
B-glycerolphosphate + Pb^ enzyme » glycerol + PbPO* 
After incubation the sections were washed in cacodylate wash buffer, post-
fixed, stained en bloc, dehydrated and embedded in the same manner as the 
morphological samples. 
Aryl sulfatase 
Aryl sulfatase activity was localized by a modification of the method 
of Hopsu-Havu et al. (109). Aryl sulfatases A & B, which are lysosomal in 
location, preferentially cleave p-nitrocatecholsulfate at acid pH while 
aryl sulfatase C, which is nonlysosomal in location, does not (108). This 
technique originally specified an acetate buffer, but the use of acetate 
resulted in poor fine structure preservation. Tris-maleate buffer (0.2 M), 
which gives excellent fine structural preservation without affecting 
cytochemical localization, was substituted for the acetate buffer. The 
incubation medium consisted of the following components: 
40 mg p-nitrocatecholsulfate in 1.0 ml doubly distilled water 
3 ml 0.1 M Tris-maleate buffer, pH 5.0 
1 ml 8% PbNOs (fresh) 
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Parallel substrateless controls were run for each localization. The 
tissue was incubated for 30-45 minutes at 37°C. The reaction depended on 
the liberation of an end product which formed an insoluble precipitate 
with lead ion. 
p-nitrocatecholsulfate + Pb^ enzyme ^ p-nitrocatechol + PbSO» 
After incubation the sections were washed in cacodylate wash buffer, post-
fixed, stained en bloc, dehydrated and embedded in the same manner as the 
morphological samples. 
Catalase 
Catalase activity was localized by the method of Novikoff and 
Goldfischer (156). The incubation medium consisted of the following 
components: 
9.8 ml 0.05 M 2-amino-2-methyl 1,3 propandiol at pH 10 
0.2 ml 1% hydrogen peroxide 
20 mg 3-3' diaminobenzidene 
Parallel controls, for each localization, were run without substrate or 
with the catalase inhibitor 1,2,4 aminotriazole (10 mM). The tissue was 
incubated for 30 minutes at 37°C. 
The localization is based on the polymerization of 3-3' diamino­
benzidene in the presence of molecular oxygen. Catalase releases molecu­
lar oxygen from hydrogen peroxide which in turn polymerizes the substrate. 
The polymerized 3-3' diaminobenzidene is osmophilic and reduces osmium 
tetroxide resulting in a black, electron dense deposit at the site of 
polymerized 3-3' diaminobenzidene. After incubation the sections were 
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washed in cacodylate wash buffer, post-fixed, stained en bloc, dehydrated 
and embedded in the same manner as the morphological samples. 
Aryl sulfatase-catalase 
Both aryl sulfatase and catalase were localized in the same tissue 
block. The reaction conditions were the same as above for each enzyme, 
with aryl sulfatase localized first followed by catalase. The tissue 
blocks were washed in cacodylate buffer for 1 hour between the two reac­
tions. After completion of the reactions, the tissue was washed in caco­
dylate wash buffer, post-fixed, stained en bloc, dehydrated and embedded 
as above (11). 
Biochemistry 
Tissue samples were homogenized in 20% W/V cold 1% KCl with 0.5% 
Triton X-100 added using a Tekmar polytron homogenizer operated at medium 
speed. Dilutions were made with 1% KCl with .01% Triton X-100 added. 
Protein 
Total protein was determined by the method of Lowry et al. (123). 
Reagents : 
Soluti on A 
2% NazCOs in doubly distilled water 
Solution B 
0.5% CuSOt'S HiO in 1% sodium tartrate 
Test solution: 
99 ml solution A + 1 ml solution B made fresh daily 
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Protein determination: 
4 ml doubly distilled water 
0.5 ml protein sample 
0.5 ml 1 N NaOH 
5.0 ml test solution 
This was allowed to stand at room temperature for 1 hour. Then 0.5 ml 1 N 
phenol reagent was added, the sample shaken and read at 660 nm after 10 
minutes. A standard curve was made using known concentrations of bovine 
serum albumin. The final protein concentration was expressed as mg 
protein/ml of homogenate. 
Inorganic phosphate 
Inorganic phosphate was determined by the method of Fiske and 
Subbarow (73). 
Stock solutions: 
10 N H2SO4 
2.5% sodium molybdate in 3.0 N H2SO4 
0.25% aminonapthol sulfonic acid in a solution of 195 ml of 15% 
sodium bisulfite and 5 ml 20% sodium sulfite (Fiske-Subbarow 
reducing agent) 
Determination of Pi concentration: 
4.6 ml doubly distilled water 
0.4 ml unknown sample containing Pi 
0.4 ml 10 N H2SO4 
0.8 ml 2.5% sodium molybdate solution 
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0.4 ml "Fiske-Subbarow reducing agent" 
3.4 ml doubly distilled water 
This solution was allowed to stand at room temperature for 10 minutes and 
then the absorbance was read at 660 nm. A standard curve was constructed 
using known concentrations of Pi. 
Lysosomal enzymes 
Five enzymes with lysosomal distribution were assayed: B-glycerol-
phosphatase, aryl sulfatase (including aryl sulfatases A and B), cathepsin 
D, B-glucuronidase and a-D-mannosidase. 
B-glycerolphosphatase (acid phosphatase) B-glycerolphosphatase 
was assayed according to the method of Seed et al. (186). The incubation 
medium consisted of the following components: 
0.4 ml commercial citrate buffer pH 4.8 (Sigma Chemical Co.) 
0.3 ml 0.1 M B-glycerolphosphate in doubly distilled water 
0.1 ml of 0.01 M MgClz 
0.2 ml enzyme preparation 
The samples were incubated for 30 minutes at 37°C in a water bath. The 
reaction was stopped with 0.2 ml cold 33% TCA, placed in an ice bath for 
10 minutes, and centrifuged; the supernatant was assayed for inorganic 
phosphate. The results were expressed as u moles Pi/mg protein/hour. 
Aryl sulfatase Aryl sulfatase activity was assayed by the 
hydrolysis of p-nitrophenyl sulfate into p-nitrophenol and sulfate ion 
(190). The incubation medium consisted of the following components: 
0.5 ml of 0.2 M Na acetate buffer, pH 5.0 
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0.4 ml 0.00625 M p-nitrophenyl sulfate 
0.1 ml enzyme preparation 
The samples were incubated at 37°C for 30 minutes in a water bath. The 
reaction was stopped by adding 5.0 ml of 0.1 N NaOH, and after 10 minutes 
the absorbance of each tube was read at 410 nm. P-nitrophenol is color­
less at acid or neutral pH but has an absorbance peak at 410 nm in a basic 
solution. A series of known concentrations of p-nitrophenol were used to 
construct a standard curve. 
Cathepsin D Cathepsin D was assayed according to the method of 
Anson (10). This assay is based on the hydrolysis of hemoglobin into TCA 
soluble amino acids and polypeptides. The substrate medium consisted of 
the following components: 
50 ml 5.0% W/V Sigma Type II hemoglobin dialyzed for 48 hours against 
doubly distilled water in the cold 
25 ml 1.35 M acetate buffer, pH 3.8 
50 ml doubly distilled water 
The incubation medium consisted of the following components: 
1.0 ml substrate solution 
0.5 ml enzyme preparation 
The samples were incubated in a water bath for 30 minutes at 37°C. The 
reaction was stopped with 3-0 ml of cold 5% TCA, and filtered through What­
man #42 filter paper; 1.0 ml of the filtrate transferred to a clean test 
tube. Two ml of 0.5 N NaOH followed by 0.6 ml of 2 N phenol reagent was 
added to the filtrate. Exactly five minutes after addition of the phenol 
reagent, the absorbance of each tube was read at 660 nm. A standard curve 
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was made using known concentrations of tyrosine as the standard, with 
1.0 mole of tyrosine equal to 1.0 mole of reaction product. 
B-glucuronidase 
B-glucuronidase activity was determined by the hydrolysis of 
phenolphthalein glucuronic acid to phenolphthalein and glucuronic acid 
according to the Sigma B-glucuronidase assay system (198). A serum blank 
and a test sample were prepared in the following manner: 
Serum blank / 
0.3 ml acetate buffer stock #105-12 
0.1 ml doubly distilled water 
0.1 ml enzyme preparation 
Test 
0.3 ml acetate buffer stock #105-12 
0.1 ml phenolphthalein glucuronic acid solution stock #325-2 
0.1 ml enzyme preparation 
Reagent blank 
0.3 ml acetate buffer stock #105-12 
0.1 ml phenolphthalein glucuronic acid solution stock #325-2 
0.1 ml doubly distilled water 
The tubes were incubated for 30 minutes at 56°C in a water bath. The 
absorbance of each tube was read at 550 nm, and a corrected absorbance 
determined as follows: 
\est "*serum + Veagent' = "'"'•«cte'l absorbance 
A standard curve was constructed using known concentrations of phenol­
phthalein. 
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a-D-mannosidase 
a-D-mannosidase activity was determined by the method of DeWald and 
Touster (57). The assay is based on the hydrolysis of p-nitrophenyl-a-D-
mannoside into p-nitrophenol and mannose. The incubation medium consisted 
of the following components: 
0.1 ml 1 mM p-nitrophenyl-a-D-mannoside 
0,3 ml 0.05 M sodium acetate buffer, pH 4.5 
0.1 ml enzyme preparation 
The samples were incubated for 30 minutes at 37°C in a water bath. The 
reaction was stopped by addition of 5.0 ml of 0.1 N NaOH. P-nitrophenol 
is colorless at acid or neutral pH but has an absorbance peak at 410 nm in 
alkaline solution. The tubes were read at 410 nm, and a standard curve was 
constructed using known concentrations of p-nitrophenol. 
Golgi apparatus marker enzyme 
UDP-galactose-n-acetylglucosamine transferase is an enzyme associated 
with the Golgi apparatus. The activity of this enzyme was assayed by the 
method of Morre et al. (141). The substrate solution consisted of the 
following components: 
20 mM tris-HCl at pH 7.5 
10 mM MgClz 
5 mM MnClz 
50 mM mercaptoethanol 
4.5 mM n-acetylglucosamine 
.322 mM UDP-i*C-galactose 
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The incubation medium consisted of: 
0.1 ml substrate 
0.1 ml enzyme preparation 
The sample was incubated for 10 minutes at 37®C in a water bath, and 
stopped by placing the reaction mixture on a 1 ml packed column of BioRad 
AGiXz ion exchange resin. N-acetylaminolactose was eluted by three 0.4 ml 
washes with doubly distilled water. A control, minus the enzyme prepara­
tion, was run to correct for autohydrolysis. The samples were mixed with 
15 ml of BioFluor and counted in a Beckman LS 250 liquid scintillation 
counter. 
Endoplasmic reticulum marker enzyme 
Glucose-6-phosphatase was used as a marker for endoplasmic reticulum. 
The enzyme was assayed by the method of Swanson (202). The incubation 
medium consisted of the following components: 
0.1 ml of 0.1 M glucose 6-phosphate (Na salt) 
0.1 ml of 0.1 M malic acid buffer, pH 5.5 
0.1 ml enzyme preparation 
The samples were incubated at 37°C for 30 minutes in a water bath. The 
reaction was stopped with 1.0 ml of 5% TCA and placed in an ice bath. 
After 10 minutes, the sample was centrifuged and assayed for inorganic 
phosphate by the Fiske-Subbarow method (73). 
Peroxisome marker enzyme 
Catalase activity was assayed as a marker for peroxisomes by the 
method of Leighton et al. (122). The reagents and incubation medium were 
as follows: 
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Reagents 
Catalase stock solution: 
50 ml of 0.2 M imidazole buffer at pH 7 
1.5 g bovine serum albumin 
125 ml 1.0 M sucrose 
10 g NaCl 
325 ml doubly distilled water 
Stop solution: 
6.7 g TiSO* in 1 liter of boiling 2 N H2SO4 filtered through 
Whatman #42 filter paper and brought to 1500 ml with 2 N H2SO4 
Incubation medium 
The stock solution was divided into two parts and 0.4 ml of H2O2 
was added to one part. This was labeled SC, while the remainder 
was labeled BC. To each of two tubes, 0.1 ml of SC was added 
followed by 0.1 ml of enzyme preparation (SCi) or 0.1 ml of 
homogenization medium (SC2). This process was repeated with BC 
to make tubes BCi and BC2. 
The tubes were incubated for 10 minutes at 27®C, and the reactions stopped 
with 5 ml of ice cold stop solution. The tubes were incubated for 10 more 
minutes at 27°C, and then tïïêir absorbances were read at 405 nm. Tube BCi 
serves as a blank for SCi and BC2 for SC2. SC1-BC1/SC2-BC2 = activity 
which is plotted as log activity. One unit of activity is the amount of 
enzyme needed to cause a tenfold decrease in the log activity in one hour. 
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RESULTS 
The results can be divided into two sections: 1) morphology and 
cytochemistry and 2) biochemistry. 
Morphology and Cytochemistry 
The morphology and cytochemistry studies on Triton WR 1339 treated 
hepatocytes encompasses several stages. 
Control 
Examination of hepatocytes following overnight starvation indicates 
that rough endoplasmic reticulum, microbodies and mitochondria are dis­
tributed in the cell as described by Bruni and Porter (37). Dense peri­
canalicular structures and multivesicular bodies, both of which are 
secondary lysosomes, are seen near the bile canliculus (Figures 1 and 2). 
Multivesicular bodies are probably formed from the fusion of smaller 
pinocytotic vesicles and primary lysosomes (Inset Figure 2). The Golgi 
apparatus is present as a series of flattened cisternae lying near the 
bile canaliculus (Figures 1 and 2). Mitochondria and microbodies are 
scattered throughout the cell with the exception of a zone of exclusion 
around the Golgi apparatus and pericanalicular lysosomes (Inset Figure 2). 
Microbodies are single-membrane limited and have dense cores, which dis­
tinguish them from the other single-membrane limited structures, lyso­
somes. Lysosomes in control tissue are about 0.7 um in diameter as com­
pared to 0.9 um for microbodies and 1.3 um for mitochondria. This repre­
sents a typical distribution of lysosomes, Golgi apparatus, microbodies, 
mitochondria and endoplasmic reticulum. 
Figure 1. Normal rat liver hepatocyte showing relationship of: 
mitochondria (M), rough endoplasmic reticulum (rer), 
microbodies (mb), Golgi apparatus (G) and lysosomes 
(L) to the bile canaliculus (be). Line scale equals 
1 um. 
Figure 2. Normal rat liver hepatocyte showing relationship of: 
mitochondria (M), microbodies (mb), rough endoplasmic 
reticulum (rer), Golgi apparatus (6) and lysosomes (L) 
to the bile canaliculus (be). Line scale equals 1 um. 
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Cytochemical localization of the lysosomal enzyme, acid phosphatase 
(B-glycerolphosphatase), in control hepatocytes visualizes the peri­
canalicular dense structures (Figures 3 and 4). Cytochemically positive 
organelles are seen on both sides of the bile canaliculus. Examination of 
unstained sections of the same material reveals several intensely positive 
organelles, secondary lysosomes (Figure 4). In some cases elements of the 
smooth endoplasmic reticulum lie close to these acid phosphatase stained 
lysosomes (Inset Figure 4). Also, sme lysosomes and the Golgi apparatus 
are located in an exclusion zone surrounded by mitochondria (Figure 4). 
Simultaneous cytochemical identification of both microbodies and lysosomes 
should reveal the possible fusion of these organelles under the experi­
mental conditions used in this study (37). Catalase localizations are 
visualized by the diamânobenzidene method described earlier (156) which 
uniquely demonstrates the presence of microbodies (Figures 5 and 6). 
Thus, microbodies are seen in the region of the bile canaliculus and 
scattered throughout the rest of the cell (Figure 5). They are different 
structures from the lysosomes described above. Higher magnification 
catalase localizations show multivesicular bodies that are not cyto­
chemical ly positive and several microbodies that are catalase positive. 
This observation supports the idea that the two structures are separate 
organelles (Figure 6). 
Triton WR 1339 treatment 
These time intervals are characterized by increases in autophagy and 
by increased hypertrophy of the Golgi apparatus. 
Figure 3. Acid phosphatase localization in normal tissue. Mito­
chondria (M) and acid phosphatase positive Tysosomes 
(L) near the bile canaliculus (be). Line scale equals 
2 urn. 
Figure 4. Acid phosphatase localization in normal tissue. Mito­
chondria (M), smooth endoplasmic reticulum (ser) and 
acid phosphatase positive Tysosomes (L). Unstained. 
Line scale equals 2 um. 

Figure 5. Catalase localization in normal tissue. Mitochondria (M), 
lysosomes (L), rough endoplasmic reticulum (rer) and 
catalase positive microbodies in relation to the bile 
canaliculus (be). Line scale equals 0.5 um. 
Figure 6. Catalase localization in normal tissue mitochondria (M), 
lysosomes (L) and catalase positive microbodies (mb) 
near the bile canaliculus (be). Note the difference 
between the multivesicular body lysosome (L) and the 
catalase positive structures (mb). Line scale equals 
0.1 um. 
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Time interval 1 (thirty minutes) At thirty minutes post-injec­
tion, there is little change in overall cellular morphology and organelle 
distribution seen in low magnification images (Figures 7 and 8). A few 
lysosomes (dense bodies) have some translucent areas in them that may be 
due to Triton WR 1339 uptake since Triton WR 1339 in lysosomes is electron 
lucid (93,94,222). However, the material cannot be positively identified 
as Triton WR 1339. No increase in number or size of lysosomes is ob­
served. The sinusoidal border of the hepatocyte does not have a Golgi 
apparatus or any lysosomes associated with it (Figure 8). An exclusion 
zone around the Golgi apparatus and most of the lysosomes can still be 
seen. The Golgi apparatus mature face is oriented parallel to the bile 
canaliculus (Figure 7). The rough endoplasmic reticulum appears to be 
normally distributed and there is no apparent change in the amount of 
either rough or smooth endoplasmic reticulum. No apparent change in the 
distribution of lysosomes, microbodies or mitochondria can be seen in 
these sections (Figures 7 and 8). 
Higher magnification images of the Golgi apparatus and lysosomes show 
little change from the normal morphology (Figures 9-11). The mature face 
of the Golgi apparatus is still oriented parallel to the bile canaliculus 
and one profile is partially rounded, typical of an active secretory 
state (Figure 9). There appear to be small Golgi vesicles in the region 
of the mature face of the Golgi apparatus (Figures 9 and 11), and evidence 
of multivesicular body formation and apparent autophagy are seen (Figure 
9 ) .  
Figure 7. Thirty minutes post-injection Triton WR 1339 showing rough 
endoplasmic reticulum (rer), nucleus (N), Golgi apparatus 
(G), and lysosomes (L) and their relationship to the bile 
canaliculus (be). There is no apparent change from normal 
in the tissue morphology. Line scale equals 1 um. 
Figure 8. Thirty minutes post-injection of Triton WR 1339 showing the 
relationship of the rough endoplasmic reticulum (rer), 
nucleus (N) and lysosomes (L) to the bile canaliculus (be). 
Cell morphology is unchanged from the normal. Line scale 
equals 1 um. 

Figure 9. Thirty minutes post-injection of Triton WR 1339 showing 
rough endoplasmic reticulum (rer), mitochondria (M), Golgi 
apparatus (G) and lysosomes (L) and their relation to the 
bile canaliculus (be). There is no increase in size or 
number of lysosomes (L) but the Golgi apparatus (G) is 
rounded and appears to be in a secretory state. Line 
scale equals 5 um. 
Figure 10. Thirty minutes post-injection of Triton WR 1339 showing 
mitochondria (M), rough endoplasmic reticulum (rer), 
nucleus (N) and lysosomes (L). The lysosomes are the 
typical dense body type seen in normal liver. The other 
organelles appear normal. Line scale equals 1 um. 
Figure 11. Thirty minutes post-injection of Triton WR 1339 showing 
the relationship of mitochondria (M) and the Golgi 
apparatus (G) to the bile canaliculus (be). The Golgi 
apparatus in this section is flattened but there is 
evidence of increased packaging with vesicles in the 
region of the mature face. Line scale equals 1 um. 
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After thirty minutes post-injection with Triton WR 1339, myelin 
figures appear. In the past myelin figures have been considered arti­
facts, but examples from many pathologies indicate that they are lysosomes 
filled with undigestible substances derived from autophagy or heterophagy. 
The membrane whorls of myelin figures seen at this time react positively 
for the lysosomal enzyme aryl sulfatase, and may be presumed to be lyso­
somes (Figure 12). Also, inclusion of mitochondrial profiles within 
cytochemically positive lysosomes indicates increased autophagic activity 
(Figure 13), and similar aryl sulfatase localization in the Golgi appara­
tus and several multivesicular bodies suggests that lysosomal enzymes are 
being packaged by the Golgi apparatus (Figure 14). 
A normal distribution of acid phosphatase in lysosomes and in the 
Golgi apparatus is seen (Figures 15 and 16), but the simultaneous demon­
stration of acid phosphatase in the Golgi apparatus and visualization of 
several lysosomes in the immediate area substantiates the premise that new 
lysosomes are formed (Figure 15). Acid phosphatase is evenly distributed 
throughout the lysosomal matrix in typical liver lysosomes, and there is 
no evidence of Triton WR 1229 uptake in these lysosomes. None of the 
cytochemical localizations appear in organelles other than the Golgi 
apparatus or lysosomes. 
Time interval 2 (one hour) Morphological examination of hepato-
cytes from livers of animals injected with Triton WR 1339 one hour before 
sacrifice indicates a massive increase in autophagic activity as demon­
strated by large membrane bound vacuoles in the region of the smooth 
endoplasmic reticulum (Figures 17, 19 and 20) and in the region of the 
Figure 12. Thirty minutes post-injection with Triton WR 1339 tissue 
incubated to localize aryl sulfatase. Note the dense black 
precipitate in the myelin figure (L arrow) and in the 
secondary lysosome (L). These structures are typical of 
the pericanalicular dense bodies seen in hepatocytes. Line 
scale equals 0.1 urn. 
Figure 13. Thirty minutes post-injection with Triton WR 1339 tissue 
incubated to localize aryl sulfatase. Mitochondria (M) 
and an autophagic lysosome (L) containing the partially 
digested remnants of a mitochondrion (*). Line scale 
equals 0.1 um. 

Figure 14. Thirty minutes post-injection with Triton WR 1339 tissue 
incubated to localize aryl sulfatase. Both the Golgi 
apparatus (G) and multivesicular body (mvb) are positive. 
Several of the small vesicles in the region of the Golgi 
apparatus forming face are also positive. Line scale 
equals 0.1 um. 
Figure 15. Thirty minutes post-injection with Triton WR 1339 tissue 
incubated to localize acid phosphatase. The forming face 
of the Golgi apparatus (G) and the lysosomes (L) contain 
reaction product. Line scale equals 0.1 um. 
Figure 16. Thirty minutes post-injection with Triton WR 1339 tissue 
incubated to localize acid phosphatase. Two typical dense 
body lysosomes (L) containing reaction are seen in an un­
stained section. Line scale equals 0.1 um. 
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Figure 17. One hour post-injection with Triton WR 1339. The lysosoroes 
(L) and mitochondria (M) appear normal. There are several 
forming autophagic vacuoles in proximity to the smooth 
endoplasmic reticulum. In this section these structures 
do not contain any recognizable cellular components. Line 
scale equals 1 um. 
Figure 18. Che hour post-injection with Triton WR 1339. The mito­
chondria (M) appear normal, but there is evidence of auto­
phagic vacuole (AV) formation in the region of the Golgi 
apparatus (G). The ends of the Golgi cisternae are dis­
tended and appear to be involved in formation of the auto­
phagic vacuole. Line scale equals 1 um. 

Figure 19. One hour post-injection with Triton WR 1339. Dense body 
lysosomes (L) and mitochondria (M) are seen in the region 
of the bile canaliculus (be). There is evidence of auto­
phagic vacuole (AV) formation in the smooth endoplasmic 
reticulum. In this case dense material is seen in one 
loop of the forming autophagic vacuole. Line scale equals 
1 um. 
Figure 20. One hour post-injection with Triton WR 1339. Autophagic 
vacuoles (AV) are forming off the smooth endoplasmic 
reticulum. There is dense cellular material associated 
with the forming autophagic vacuole (AV). Line scale 
equals T um. 
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Golgi apparatus (Figure 18) and by dense material inside these vacuoles 
(Figures 19 and 20). Also, autophagy seems to be occurring in the peri­
canalicular region (Figures 18-20). There, the lysosomes appear to be 
dense bodies and no evidence of Triton WR 1339 accumulation is observed in 
these structures (Figure 19). All other organelles appear similar to 
those described in control tissue including mitochondria which are scat­
tered evenly throughout the cell. 
At one hour post-injection acid phosphatase is observed in the Golgi 
apparatus and in lysosomes. This lysosomal enzyme is localized in the 
mature face of the Golgi apparatus and in lysosomes that contain some 
partially digested material (Figure 21). Morphological studies suggest 
vacuolation of the mature face of the Golgi apparatus leading to lysosome 
formation. Lysosomes also exhibit localization of acid phosphatase reac­
tion product (Figure 22) and smooth endoplasmic reticulum is observed to 
form acid phosphatase positive loops suggestive of autophagic vacuole 
formation (Figure 23). There appears to be partially digested material in 
the ends of the forming autophagic vacuole. Acid phosphatase positive 
organelles, lysosomes, contain an electron lucid material similar to 
Triton WR 1339. 
In similar preparations, aryl sulfatase is located in lysosomes con­
taining whorls similar to those previously observed at interval 1 (Figure 
25). In all the cytochemical localizations, the cellular ultrastructure 
is unaltered. 
Time interval 3 (three hours) Three hours post-injection with 
Triton WR 1339 lysosome size and number has not changed. Triton WR 1339 
Figure 21. One hour post-injection with Triton WR 1339, acid phos­
phatase localization. The mature face of the Golgi 
apparatus (G) and the secondary lysosome (L) contain 
reaction product. The product is associated with dense 
material in both cases, probably representing the lyso­
somal matrix. Line scale equals 0.1 urn. 
Figure 22. One hour post-injection with Triton WR 1339, acid phos­
phatase localization. The dense granular reaction 
product is localized within membrane bound structures, 
the lysosomes (L). Line scale equals 0.1 um. 
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Figure 23. One hour post-injection with Triton WR 1339 acid phos­
phatase localization. A dense reaction product is 
localized within forming autophagic vacuole (AV) which 
resembles an element of the smooth endoplasmic reticulum. 
Line scale equals 0.1 um. 
Figure 24. One hour post-injection with Triton WR 1339 acid phos­
phatase localization. Dense reaction product is localized 
in one lysosome (L) while another near it does not contain 
any product. Line scale equals 0.1 um. 
Figure 25. One hour post-injection with Triton WR 1339 aryl sulfatase 
localization. The reaction product is confined to the 
membranous whorls in the myelin figure-like secondary lyso­
some (L). Line scale equals 0.1 um. 
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appears to have accumulated in some lysosomes (Figure 26). The Golgi 
apparatus is elongated and the mature face is distended with Golgi vesi­
cles present in the region of the mature face. There is some prolifera­
tion of the smooth endoplasmic reticulum, but mitochondria and microbodies 
are distributed as in the control. 
At this time interval, acid phosphatase reaction product is seen in 
Triton WR 1339 filled lysosomes that contain membrane whorls and in lyso­
somes near the bile canaliculus that contain partially digested material 
(Figure 28). There is no evidence of any change in the structure or 
distribution of mitochondria or microbodies in these morphological and 
cytochemical studies (Figures 27 and 28). 
Time interval 4 (six hours) At six hours post-injection, Triton 
WR 1339 filled lysosomes are positive for acid phosphatase (Figures 29-
32). These lysosomes appear in the pericanalicular region and frequently 
contain undigested material including remnants of mitochondria (Figures 
29-31). The other cellular components appear normal, but the presence of 
remnants of subcellular structures within the lysosomes indicates con­
tinuing autophagy (Figure 31). 
Time interval 5 (twelve hours) By twelve hours post-injection the 
accumulations of Triton WR 1339 in lysosomes have become more apparent. 
At low magnifications both dense body and Triton WR 1339 filled lysosomes 
are observed, and in some cases large secondary lysosomes are seen 
(Figures 33 and 34). The size of the average lysosome is still much 
smaller than mitochondria. Lysosomes are still concentrated in the 
Figure 26. Three hours post-injection with Triton WR 1339. Normal 
cellular distribution of the smooth endoplasmic reticulum 
(ser), mitochondria (M) and lysosomes (L). The Golgi 
apparatus (G) is elongated and partially rounded. There 
is evidence of Golgi vesicles in the region of the mature 
face. Tnis is all indicative of an actively packaging 
Golgi apparatus. Line scale equals 0.1 um. 
Figure 27. Three hours post-injection with Triton WR 1339, acid phos­
phatase localization. Both myelin figure and Triton WR 
1339 filled (L) lysosomes are present. The reaction 
product is associated with the membrane whorls or with 
the lysosomal matrix. Line scale equals 0.1 um. 
Figure 28. Three hours post-injection with Triton WR 1339, acid phos­
phatase localization. The reaction product is localized 
in secondary lysosomes (L) which appear to contain par­
tially digested cellular components. Line scale equals 
0.1 um. 

Figure 29. Six hours post-injection with Triton WR 1339, acid phos­
phatase localization in a secondary lysosome (L). Line 
scale equals 0.1 urn. 
Figure 30. Six hours post-injection with Triton WR 1339, acid phos­
phatase localization. The reaction product is localized 
in a Triton WR 1339 filled secondary lysosome (L) which 
is in the pericanalicular region. Line scale equals 0.1 
urn. 
Figure 31. Six hours post-injection with Triton WR 1339, acid phos­
phatase localization. The reaction product is localized 
in membrane whorls in a secondary lysosome (L). Line 
scale equals 0.1 um. 
Figure 32. Six hours post-injection with Triton WR 1339, acid phos­
phatase localization. The reaction product is localized 
in a secondary lysosome (L) containing a partially di­
gested mitochondrion (*). Line scale equals 0.1 um. 
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Figure 33. Twelve hours post-injection with Triton WR 1339. The 
appearance of the mitochondria (M) and the Golgi apparatus 
(G) which is seen both in cross section (single arrow) and 
en face (double arrow) is normal. Both dense body and 
Triton WR 1339 filled lysosomes (L) are seen. Line scale 
equals 1 urn. 
Figure 34. Twelve hours post-injection with Triton WR 1339. Both 
small dense body and larger Triton WR 1339 filled lyso­
somes (L) are seen. The Golgi apparatus again appear to 
be involved in autophagic activity. Line scale equals 
0.1 urn. 

68 
pericanalicular region, and there is no change in the size of intra­
cellular distribution of the mitochondria or tnicrobodies. 
At this time interval, Triton WR 1339 filled lysosomes are more 
evident. Both Triton WR 1339 filled lysosomes and dense bodies are seen 
(Figures 35 and 36). Lysosomes of both the above types appear to be 
fusing (Figure 35). In some areas Triton WR 1339 filled lysosomes have 
already fused (Figure 36). Autophagic vacuole formation and myelin figure 
formation often occur in the pericanalicular region (Figure 37). Auto-
phagy is evident with both folding of the smooth endoplasmic reticulum and 
distension of the mature face of the Golgi apparatus being observed during 
autophagic vacuole formation (Figure 37). However, there does not appear 
to be an increase in Golgi derived vesicles as compared to the controls. 
In twelve hours post-injection samples, both myelin figure and Triton 
WR 1339 filled lysosomes are aryl sulfatase positive. These structures 
are present in the pericanalicular region, and some evidence of autophagy 
is observable (Figures 39 and 40). Occasional fusion of autophagic 
vacuoles with aryl sulfatase positive lysosomes is evident (Figure 40). 
Cytochemical localization for catalase indicates that lysosomes and 
microbodies do not fuse at this stage (Figures 41 and 42). 
Accumulation of Triton WR 1339 
This stage is characterized by the accumulation of Triton WR 1339 in 
lysosomes and by an increase in lysosome size. 
Time interval 6 (twenty-four hours) By 24 hours post-injection, 
autophagy seen between 1 and 12 hours post-injection has diminished. 
Distinct Triton WR 1339 filled lysosomes are often seen concentrated in 
Figure 35. Twelve hours post-injection with Triton WR 1339. Dense 
body and Triton WR 1339 filled secondary lysosomes (L) are 
seen in the pericanalicular region. Line scale equals 
1 urn. 
Figure 36. Twelve hours post-injection with Triton WR 1339. Dense 
body and Triton WR 1339 filled secondary lysosomes (L) 
are seen near the bile canaliculus. In some profiles 
the Triton WR 1339 filled lysosomes appear to be fusing. 
The Golgi apparatus (G) exhibits packaging activity with 
small Golgi vesicles seen near the mature face. The rough 
endoplasmic reticulum (rer) and mitochondria (M) appear 
normal. Line scale equals 1 um. 
Figure 37. Twelve hours post-injection with Triton WR 1339. Autophagic 
vacuoles (AV) are forming in loops off the smooth endo­
plasmic reticulum. Triton WR 1339 filled lysosomes (L) are 
present in the pericanalicular region. Line scale equals 
1 um. 

Figure 38. Twelve hours post-injection with Triton WR 1339 aryl sulfa-
tase localization. The nucleus (N), mitochondrion (M) and 
rough endoplasmic reticulum (rer) appear normal. The 
reaction product is localized in myelin figure and Triton 
WR 1339 filled lysosomes (L). Most of these structures are 
in the pericanalicular region. Line scale equals 1 um. 
Figure 39. Twelve hours post-injection with Triton WR 1339 aryl sulfa-
tase localization. The reaction product is localized in 
the Golgi apparatus (G) and both myelin figure and Triton 
WR 1339 filled secondary lysosomes (L). Line scale equals 
1 um. 
Figure 40. Twelve hours post-injection with Triton WR 1339 aryl sulfa-
tase localization. The reaction product is confined to the 
dense parts of the lysosomes (L). In one case aryl sulfa-
tase positive lysosome is fusing with an autophagic vacuole 
containing a partially digested mitochondrion (*). Line 
scale equals 1 um. 
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Figure 41. Twelve hours post-injection with Triton WR 1339, catalase 
localization. The dense reaction product is localized in 
microbodies (mb). Autophagic vacuoles (AV) and Triton WR 
1339 filled secondary lysosomes (L) are also present. 
Line scale equals 1 urn. 
Figure 42. Higher magnification of Figure 41. The diaminobenzidene 
reaction product is localized in densely stained micro-
bodies, while lysosomes (L) and autophagic vacuoles (AV) 
are unstained. Line scale equals 1 urn. 
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the pericanalicular region. Characteristically these organelles appear 
swollen, and the lumen of the organelles appears to be filled with elec­
tron lucid material, while there is a dense core at the periphery of the 
lysosomes (Figure 43). Occasional myelin figures, reminiscent of earlier 
structures, appear in the pericanalicular region (Figure 43). Higher 
magnification examination reveals that the dense peripheral core of the 
Triton WR 1339 filled lysosomes closely resembles the luminal contents of 
dense bodies (Figure 44). The Golgi apparatus is still elongated and 
rounded, and a few vesicles are seen near the mature face (Figure 45). 
Occasional vacuolization in the region of the mature face of the Golgi 
apparatus suggests a continuing involvement in autophagy (Figure 45). 
Profiles of omega figures, presumptive lysosomes in which the lysosomal 
lumen is continuous with the extracellular space, are seen occasionally 
(Figure 45 (37)). There is no obvious change in the number or intra­
cellular distributions of mitochondria, rough endoplasmic reticulum and 
microbodies as compared to controls. No proliferation of the smooth 
endoplasmic reticulum is observed, and although the nucleus occasionally 
appears ruffled, this is probably a normal variation as the condition does 
not persist in later stages. 
Triton WR 1339 filled translucent structures and myelin figures are 
acid phosphatase positive (Figures 47-49). In the Triton WR 1339 filled 
structures, the cytochemically positive area has been pushed to the side. 
This is probably due to the Triton WR 1339 concentration forcing the pro-
teinaceous material to one side. Occasional lysosomal fusion is sugges­
tive of continuing hydrolytic enzyme delivery to the Triton WR 1339 filled 
Figure 43. Twenty-four hours post-injection with Triton WR 1339. The 
mitochondria (M) and rough endoplasmic reticulum appear 
normal. The lysosomes (L) are either the Triton WR 1339 
filled or myelin figure type with the former being more 
numerous. The lysosomes are still in the pericanalicular 
region. Line scale equals 1 um. 
Figure 44. Higher magnification of twenty-four hours post-injection 
tissue. The Triton WR 1339 filled lysosomes (L) are more 
obvious in this figure. Line scale equals 1 um. 

Figure 45. Twenty-four hours post-injection with Triton WR 1339. The 
Golgi apparatus (G) is still rounded up and appears to be 
in a secretory state. Both autophagic vacuoles (AV) and 
Triton WR 1339 filled lysosomes (L) are seen near the 
Golgi apparatus. Line scale equals 1 urn. 
Figure 46. Twenty-four hours post-injection with Triton WR 1339. 
Lysosomes (L) appear to be dumping their contents into 
the bile canaliculus. Omega figures are seen which 
appear to contain lysosomal (0) and myelin figure 
(0 double arrow) remnants. Line scale equals 1 um. 

Figure 47. Twenty-four hours post-injection with Triton WR 1339, acid 
phosphatase localization. Acid phosphatase reaction prod­
uct is localized in Triton WR 1339 filled and myelin figure 
lysosomes (L) in the pericanalicular region (be). Line 
scale equals 1 urn. 
Figure 48. Twenty-four hours post-injection with Triton WR 1339, acid 
phosphatase localization. The reaction product is local­
ized in Triton WR 1339 filled lysosomes (L) near the bile 
canaliculus (be). Line scale equals 1 urn. 
Figure 49. Twenty-four hours post-injection with Triton WR 1339, acid 
phosphatase localization. The reaction product is local­
ized in two lysosomes (L), one myelin figure and one Triton 
WR 1339 filled. Line scale equals 0.1 urn. 
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lysosomes, while continued presence of myelin figures suggests that 
autophagy is ongoing. 
Time interval 7 (thirty-six hours) By 36 hours post-injection, 
there is an accumulation of Triton WR 1339 filled lysosomes (Figures 50 
and 51) and an apparent increase in their number. Swelling of the lyso­
somes from Triton WR 1339 accumulation is more pronounced, and the Triton 
WR 1339 filled lysosomes are now about the same diameter as the mito­
chondria. A dense peripheral core, presumably derived from the secondary 
lysosome luminal matrix, continues to be evident (Figures 50, 52 and 53). 
However, the morphology of the Golgi apparatus suggests increased packag­
ing activity, and the number of Golgi profiles seen as compared to 
earlier stages seems to indicate some hypertrophy of the organelle (Figure 
50). There appears to be an elongation of the Golgi lamellae, while the 
Golgi apparatus is often horseshoe shaped (Figure 51). Occasionally lipid 
droplets are seen, probably due to lipid mobilization by Triton WR 1339 
(222). The organelles other than the Golgi apparatus and lysosomes appear 
the same as the controls, with the exception of an increase in the number 
of dense cored microbodies. Occasionally fusion of adjacent Triton WR 
1339 filled lysosomes can be seen (Figure 53). This fusion process 
probably gives rise to the very large Triton WR 1339 filled lysosomes seen 
at later time intervals (Figures 78 and 79). 
Aryl sulfatase (Figures 54 and 57) and acid phosphatase (Figures 55 
and 56) reaction products are visualized in both myelin figures and Triton 
WR 1339 filled structures. There are a few very large secondary lysosomes 
and many smaller ones, including some that are fusing (Figure 54), and, as 
Figure 50, Thirty-six hours post-injection with Triton WR 1339. The 
appearance of the cell is normal except for an increase in 
the number of Golgi apparatus (S) profiles and for the 
presence of Triton WR 1339 filled lysosomes (L), Line 
scale equals 1 um. 
Figure 51. Thirty-six hours post-injection with Triton WR 1339. 
Elongated and rounded Golgi apparatus (6) appears to 
be packaging state. Many small Triton WR 1339 filled 
secondary lysosomes (L) are present as well as some 
large lipid droplets. Line scale equals 1 um. 

Figure 52. Thirty-six hours post-injection with Triton WR 1339. The 
Golgi apparatus (G) is rounded and appears to be packaging. 
There is evidence of autophagic vacuole formation near 
the mature face (G double arrows). All of the 1ysosones 
(L) are filled with Triton WR 1339. Line scale equals 
1 urn. 
Figure 53. Thirty-six hours post-injection with Triton WR 1339. The 
Golgi apparatus (G) shows evidence of packaging activity. 
The Triton WR 1339 filled lysosomes (L) seem to be fusing 
in some profiles (double arrows). Line scale equals 1 um. 
Figure 54. Thirty-six hours post-injection with Triton WR 1339, aryl 
sulfatase localization. The reaction product is confined 
to the rim of the Triton WR 1339 lysosomes and to the 
membranes in the myelin figures (L). Line scale equals 
1 um. 
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Figure 55. Thirty-six hours post-injection with Triton WR 1339, acid 
phosphatase localization. The reaction product is asso­
ciated with membranous structures in a Triton WR 1339 
filled secondary lysosome (L). Line scale equals 0.1 urn. 
Figure 56. Thirty-six hours post-injection with Triton WR 1339, acid 
phosphatase localization. Again the reaction product is 
confined to membranous structures in the Triton WR 1339 
filled lysosome (L). Line scale equals 0.1 um. 
Figure 57. Thirty-six hours post-injection with Triton WR 1339, aryl 
sulfatase localization. The reaction product is confined 
to the rim of the Triton WR 1339 filled secondary lyso-
somes, probably in association with the lysosomal matrix. 
Line scale equals 0.1 um. 
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before, these structures remain in the pericanalicular region. The en­
zyme reaction product in the larger lysosomes is present as a crescent 
shaped deposit suggesting the concentration of the lysosomal matrix at the 
periphery of the Triton WR 1339 filled vacuoles (Figure 57). Acid phos­
phatase (Figures 55 and 56) shows similar zones of activity, although in 
some cases the reaction product is more centrally located. 
Time interval 8 (Forty-eight hours) Liver tissues examined 48 
hours post-injection (Figure 58) show an increase in the number and size 
of Triton WR 1339 filled lysosomes in hepatocytes. Swelling of Triton WR 
1339 filled lysosomes is evident with the larger lysosomes having a diam­
eter greater than the mitochondria (Figure 59). At this time period, the 
myelin figures begin to decrease in number, and although some of these 
structures are present at later stages, they are never as numerous as 
during the first 35 hours post-injection. Although it is not as elongated 
as at earlier stages, the Golgi apparatus is still actively forming Golgi 
vesicles. Vacuolation of the mature face of the Golgi apparatus continues 
to be manifested (Figures 59 and 60). Morphological proximity of the 
Triton WR 1339 filled lysosomes to the mature face of the Golgi apparatus 
suggests continuing "lysosome packaging" (Figures 59 and 60). Evidence of 
fusion of the smaller Triton WR 1339 filled lysosomes continues to be 
seen. There is no evidence of any change in number or distribution of any 
other organelles except for a continuing increase in the number of micro-
bodies. 
Cytochemical demonstration of acid phosphatase in hepatocytes 48 
hours post-injection shows a rim of cytochemically positive material 
Figure 58. Forty-eight hours post-injection with Triton WR 1339. At 
this stage the lysosome number and size begins to increase. 
All of the identifiable lysosomes (L) in this section are 
filled with Triton WR 1339. The morphology and distribu­
tion of the other organelles, mitochondria (M) and nucleus 
(N), has not changed. Line scale equals 1 urn. 
Figure 59. Forty-eight hours post-injection with Triton WR 1339. The 
increase in lysosome size is evident in this micrograph 
with the largest Triton WR 1339 filled lysosomes (L) more 
than 1 urn in diameter. The Golgi apparatus is still 
elongated. Line scale equals 1 um. 

Figure 60. Forty-eight hours post-injection with Triton WR 1339. The 
Golgi apparatus is still packaging with small Golgi vesicles 
in the region of the mature face (G). The Triton WR 1339 
lysosomes (L) are larger than the normal dense body lyso-
somes. Line scale equals 1 urn. 
Figure 61. Forty-eight hours post-injection with Triton WR 1339, acid 
phosphatase localization. The reaction product is con­
fined to the lysosomal matrix of a Triton WR 1339 filled 
secondary lysosome (L). Line scale equals 0.1 urn. 
Figure 62. Forty-eight hours post-injection with Triton WR 1339, acid 
phosphatase localization. The reaction product is confined 
to the rim of the Triton WR 1339 filled lysosome (L) or 
to a dense matrix inside the structure. The lysosomes 
are still in a pericanalicular locaticw. Line scale 
equals 0.1 um. 
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around the edge of Triton MR 1339 filled lysosomes (Figures 61 and 62), or 
discrete areas of localization in the middle of the organelle (Figure 62). 
Structures resembling myelin figure lysosomes are present, but they are 
not as well developed as at earlier stages (Figure 62). 
Time interval 9 (three days) Three days post-injection, Triton WR 
1339 filled lysosomes can still be seen very close to the bile canaliculus 
(Figures 63 and 64). Swelling of Triton WR 1339 filled lysosomes con­
tinues to be evident with several of the lysosomes approaching the diam­
eter of mitochondria, and there is continued fusion of lysosomes with 
each other (Figure 65). A lower rate of autophagy in these cells is sug­
gested as the remnants of only a few mitochondria are seen in Triton WR 
1339 filled lysosomes (Figure 65). With the exception of large lipid 
droplets and an increase in microbodies, the number and distribution of 
other organelles is the same as the controls. 
Both myelin figures (Figures 67 and 68) and Triton WR 1339 filled 
(Figure 67) lysosomes are positive for acid phosphatase at this time 
period. The reaction product is confined to the membranes of the myelin 
figures and the edge of the Triton WR 1339 filled structures. There is 
some evidence of increased amounts of smooth endoplasmic reticulum 
(Figure 68). 
Time interval 10 (four days) At four days post-injection, the 
number of microbodies (catalase positive organelles) increased as com­
pared to the controls (Figures 5, 6, and 69). Their distribution, how­
ever, did not change as they are still evenly distributed throughout the 
Figure 53. Three days post-injection with Triton WR 1339. Lysosome 
size has increased. The lysosome (L) filled with Triton 
WR 1339 and the Golgi apparatus (G) are still peri­
canalicular. Line scale equals 1 urn. 
Figure 64. Three days post-injection with Triton WR 1339. The Triton 
WR 1339 filled lysosomes (L) are confined to the peri­
canalicular region. There is no evidence of change in 
distribution of any other organelles with the exception 
of an increase in the dense cored structures resembling 
microbodies. Line scale equals 1 urn. 
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Figure 65. Three days post-injection with Triton WR 1339. The Triton 
WR 1339 filled lysosomes (L) appear to be fusing with each 
other, and with autophagic vacuoles containing mito­
chondrial remnants (*). Line scale equals 1 urn. 
Figure 66. Three days post-injection with Triton WR 1339. The Triton 
WR 1339 filled lysosomes again appear to be fusing in some 
profiles. The lysosomal matrix in these organelles has 
been pushed to one side. Line scale equals 1 urn. 
Figure 67. Three days post-injection with Triton WR 1339, acid phos­
phatase localization. The reaction product is confined 
to myelin figure and Triton WR 1339 filled secondary lyso-
sofT-es (L). These structures are all in the pericanalicular 
region. Unstained. Line scale equals 1 um. 
Figure 68. Three days post-injection with Triton WR 1339, acid phos­
phatase localization. The reaction product is confined 
to the dense matrix along the edge of the Triton WR 1339 
filled lysosomes (L). There is fusion of a Triton WR 
1339 filled secondary lysosone and an autophagic vacuole 
(double arrows). Line scale equals 0.1 um. 
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Figure 69. Four days post-injection with Triton WR 1339, catalase 
localization. The dense osmophilic reaction product 
is confined to the microbodies (mb). There is no 
reaction in the Triton WR 1339 filled lysosomes (L). 
Unstained. Line scale equals 1 urn. 
Figure 70. Four days post-injection with Triton WR 1339, catalase 
localization. The dense osmophilic reaction product 
is confined to the microbodies (mb). There is no 
evidence of reaction product in the Triton WR 1339 
filled lysosomes (L) or in the Golgi apparatus (G). 
Unstained. Line scale equals 0.5 um. 
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cell. No evidence of fusion of microbodies and lysosomes is seen 
(Figure 70). 
Time interval 11 (five days) After five days following Triton WR 
1339 injection, the size and number of Triton WR 1339 filled lysosomes 
continues to increase. Very few of the lysosomes containing myelin 
figures are seen, probably reflecting a decrease in autophagy after 
thirty-six hours post-injection (Figure 73). Triton WR 1339 filled lyso­
somes occasionally appear to be phagocytosing part of the cytoplasm 
(Figure 73). The Golgi apparatus continues to exhibit morphological 
evidence of increased packaging activity (Figure 71) and occasionally lies 
in close spatial apposition to the Triton WR 1339 filled lysosomes (Figure 
72). There is continued evidence of Golgi apparatus hypertrophy with 
elongation of the lamellae and numerous Golgi vesicles and dense swelling 
associated with the mature face (Figures 73 and 74). The distribution and 
structure of the mitochondria and smooth endoplasmic reticulum has not 
changed, but the number of microbodies remains high. Otherwise, the 
cellular morphology is normal. 
Time interval 12 (seven days) Aryl sulfatase reaction product is 
distributed around the edge of the Triton WR.1339 filled lysosomes, but the 
product appears to be confined to a smaller area than at earlier stages 
(Figure 75). 
Time interval 13 (eight days) Hepatocytes of eight day post-
injection tissues show a continuing increase in size of the Triton WR 1339 
filled lysosomes (Figures 76 and 77). The maximum size of Triton WR 1339 
filled lysosomes in these sections is 3 um while the average is 1.5 um. 
Figure 71. Five days post-injection with Triton WR 1339. The size of 
the Triton WR 1339 filled lysosomes (L) is greater than 
that of the mitochondria (M). This increase in size is 
probably caused by Triton kR 1339 induced osmotic changes 
in the lysosomes. The Golgi apparatus (G) is still 
elongated and there are Golgi vesicles (gv) near some of 
the Triton WR 1339 filled lysosomes. Line scale equals 
1 um. 
Figure 72. Five days post-injection with Triton WR 1339. There is an 
increase in microbody (mb) number as well as an increase 
in size of the Triton WR 1339 filled lysosomes (L). The 
Golgi apparatus (G) is in close opposition to the Triton 
WR 1339 filled lysosomes in some sections (single arrow). 
The double arrows indicate an en face section through the 
Golgi apparatus. Line scale equals 1 um. 
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Figure 73. Five days post-injection with Triton WR 1339 showing the 
relationship between Triton WR 1339 filled secondary lyso-
somes (L) and the Golgi apparatus (G). Small Golgi vesi­
cles (gv) are seen in the region of the Golgi apparatus 
mature face. This is indicative of continuing synthetic 
activity. Line scale equals 1 urn. 
Figure 74. Five days post-injection with Triton WR 1339 showing an 
elongated Golgi apparatus (G) which is still actively 
packaging with small Golgi vesicles (gv) in the region 
of the mature face. Line scale equals 1 um. 
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Figure 75. Seven days post-injection with Triton WR 1339, aryl 
sulfatase localization. The product is localized in 
the lysosomal matrix at the edge of Triton WR 1339 
filled lysosomes (L). Unstained. Line scale equals 
0.1 urn. 
Figure 76. Eight days post-injection with Triton WR 1339. Large 
Triton WR 1339 filled and myelin figure lysosomes (L) 
are seen near an elongated Golgi apparatus (G). The 
Golgi apparatus is no longer as active as at earlier 
stages. There is no distension of the lamellae and 
the number of Golgi vesicles has decreased. Line 
scale equals 1 um. 
Figure 77. Eight days post-injection with Triton WR 1339. Triton WR 
1339 filled lysosomes (L) are seen close to the Golgi 
apparatus (G). In this section the Golgi does not appear 
as active as at earlier stages. Line scale equals 1 um. 
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At this stage, the cytoplasmic distribution of Triton WR 1339 filled lyso-
somes is decentralized with the lysosomes scattered throughout the cell 
(Figures 78 and 79). Evidence of fusion of these lysosomes is observed 
with the cells containing the largest number of lysosomes appearing to 
lose cellular integrity. Although the Golgi apparatus has returned to a 
normal morphological configuration, there is still some evidence of 
packaging, but not to the extent seen up to the five day post-injection 
samples (Figures 76 and 77). While the number of microbodies continues to 
increase, the size, number and distribution of the other organelles does 
not change. 
Clearance of Triton WR 1339 
Between eight and 60 days post-injection the Triton WR 1339 is 
cleared and the cell morphology resembles the controls. 
Time interval 14 (fifteen days) Cytochemical localization of acid 
phosphatase (Figures 80-82) and aryl sulfatase (Figure 83) identify the 
lysosomes found in tissue fifteen days post-injection. Both myelin figure 
and Triton WR 1339 filled lysosomes are present, although the number of 
Triton WR 1339 filled lysosomes has decreased dramatically. For the most 
part Triton WR 1339 filled lysosomes are smaller than they were between 
five and eight days. In some cases the myelin figures appear to be sur­
rounded by a second membrane (Figure 82). 
Time interval 15 (thirty days) At thirty days post-injection, 
morphological evidence of continued clearance of the Triton WR 1339 filled 
lysosomes is observed. There is a marked absence of Triton WR 1339 filled 
lysosomes (Figures 84 and 85), and there is evidence of synthesis of new 
Figure 78. Eight days post-injection with Triton WR 1339. There is 
an increase in size of the Triton WR 1339 filled secondary 
lysosomes (L) with many of them 3 urn in diameter. There 
is evidence of fusion of these structures with each other. 
One cell in the section (on the left) has many more of the 
secondary lysosomes than the others. This may indicate a 
preferential uptake of Triton WR 1339 by some hepatocytes. 
Line scale equals 1 um. 
Figure 79. Eight days post-injection with Triton WR 1339. There is an 
increase in size and number of Triton WR 1339 filled second­
ary lysosomes (L) but they are again mostly confined to one 
cell. The diameter of the largest of these lysosomes is 
more than 3 um. 

Figure 80. Fifteen days post-injection with Triton WR 1339, acid phos­
phatase localization. Structures resembling dense body 
lysosomes and myelin figure lysosomes (L) contain the 
reaction product. There is no evidence in this section 
of the Triton WR 1339 filled lysosones. Line scale 
equals 1 um. 
Figure 81. Fifteen days post-injection with Triton WR 1339, acid phos­
phatase localization. The reaction product is confined to 
lysosomes (L). Both Triton WR 1339 filled and dense body 
structures are positive. Line scale equals 1 um. 
Figure 82. Fifteen days post-injection with Triton WR 1339, acid phos­
phatase localization. The reaction product is confined to 
the membrane whorls in a large myelin figure lysosome (L). 
There is space between the myelin figure and the lysosomal 
limiting membrane (double arrows). Line scale equals 0.1 
um. 
Figure 83. Fifteen days post-injection with Triton WR 1339, aryl sulfa-
tase localization. The reaction product is localized in 
the membrane whorls of a myelin figure lysosome (L). Line 
scale equals 0.1 um. 
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Figure 84. Thirty days post-injection of Triton WR 1339. Most of the 
Triton WR 1339 filled lysosomes have cleared the cell. The 
Golgi apparatus is still packaging, but the product in the 
Golgi cisternae (G) and in the Golgi vesicles resembles 
VLDL's (very light density lipoprotein) which these cells 
synthesize rather than lysosomal matrix. The rest of the 
cell structure is normal and the number of microbodies 
has declined. Line scale equals 1 urn. 
Figure 85. Thirty days post-injection of Triton WR 1339. Only a few 
small Triton WR 1339 filled lysosomes (L) are seen in this 
section. Most of the lysosomes are multivesicular bodies 
(mvb) indicating new synthesis of lysosomal hydrolases 
and the low concentration of Triton WR 1339 at this state. 
Line scale equals 1 um. 
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dense bodies and multivesicular bodies. The number of microbodies has de­
creased while the size, number and distribution of mitochondria and smooth 
and rough endoplasmic reticulum remains the same as. the controls. 
The mature face and vesicles of the Golgi apparatus are aryl sulfa-
tase positive (Figure 86) as are the dense bodies and autophagic vacuoles 
containing mitochondria. However, while some Triton WR 1339 filled lyso-
somes are still reactive for acid phosphatase, most of the positive struc­
tures are smaller dense bodies (Figure 87). 
Time interval 16 (sixty days) By sixty days post-injection, there 
is evidence of a return to the cellular architecture seen in the controls 
(Figure 88). No large accumulations of Triton WR 1339 filled lysosomes 
are present. Normal dense bodies are seen, and all other organelles 
appear normal. Occasional autophagic vacuoles are seen as well as some 
myelin figures, but none of the large Triton WR 1339 filled structures. 
Aryl sulfatase and acid phosphatase localizations are similar to the 
controls (Figures 90 and 91), and further confirm the return to normal 
cell architecture. Most of the positive lysosomes seen are of the smaller 
dense body type (Figures 90 and 91). 
Comparison of catalase and aryl sulfatase distribution 
Because of the possibility of fusion of microbodies and lysosomes 
under these experimental conditions, localization of marker enzymes for 
both structures was performed in the same samples. A comparison of sam­
ples from time interval 4 (six hours) and time interval 14 (fifteen days) 
demonstrates the difference between these two organelles (Figures 92 and 
93). There are catalase positive microbodies and aryl sulfatase positive 
Figure 86. Thirty days post-injection with Triton WR 1339, aryl sulfa­
ta se localization. The reaction product is localized in 
the mature face of the Golgi apparatus and associated dense 
bodies (6) and in autophagic lysosomes (L) containing 
partially digested mitochondria (*). Again there are no 
accumulations of Triton WR 1339 in any of these structures. 
Line scale equals 1 um. 
Figure 87. Thirty days post-injection with Triton WR 1339, acid phos­
phatase localization. The reaction product appears in 
both Triton WR 1339 filled and dense body lysosomes (L). 
Most of the lysosome seen at this stage are the dense body 
type with very few of the Triton WR 1339 filled lysosomes. 
The dense bodies and Triton WR 1339 filled structures are 
still pericanalicular (be). Line scale equals 1 um. 
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Figure 88. Sixty days post-injection with Triton WR 1339. There are 
no Triton WR 1339 filled lysosomes in this section. The 
cell appears normal with a normal complement of dense body 
lysosomes (L) and the Golgi apparatus is normal size (G). 
The rest of the cellular structures, the mitochondria (M) 
and rough endoplasmic reticulum (rer) appear normal. Line 
scale equals 1 um. 
Figure 89. Sixty days post-injection of Triton WR 1339, aryl sulfatase 
localization. The reaction product is localized in the 
membrane whorls of two myelin figure lysosomes (L). There 
is no evidence of Triton WR 1339 filled lysosomes in this 
section. Line scale equals 1 um. 

Figure 90. Sixty days post-injection with Triton WR 1339, aryl sulfa-
tase localization. The reaction product is localized in 
a dense body lysosome (L) in the pericanalicular region. 
Line scale equals 0.1 urn. 
Figure 91. Sixty days post-injection with Triton WR 1339, acid phos­
phatase localization. The reaction product is localized 
in pericanalicular dense body lysosomes (L). There are 
still isolated Triton WR 1339 filled structures, but 
they are not cytochemically positive. These structures 
are probably residual bodies. Line scale equals 0.1 urn. 
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Figure 92. Fifteen days post-injection with Triton WR 1339 tissue 
incubated to localize catalase and aryl sulfatase. The 
catalase reaction product is confined .to the micrObodies 
(mb) while the aryl sulfatase product is localized in 
secondary lysosomes (L). There is no evidence of fusion 
of these structures. Line scale equals 1 urn. 
Figure 93. Six hours post-injection with Triton WR 1339 tissue incu­
bated to localize catalase and aryl sulfatase. The 
catalase reaction product is localized in microbodies 
(mb) while the aryl sulfatase product is localized in 
Triton WR 1339 filled lysosomes (L). There is no 
evidence that these two structures fuse at this time 
interval. Line scale equals 1 um. 
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lysosomes in these sections, but there is no evidence of fusion of the 
two. 
Biochemistry 
Total liver homogenates were assayed to determine changes in the 
specific activity of selected marker enzymes following Triton WR 1339 
injection. Markers for the following organelles were assayed: lysosomes, 
Golgi apparatus, microbodies, and endoplasmic reticulum. 
Lysosomal markers 
Originally three lysosomal marker enzymes were assayed: B-glycerol-
phosphatase (acid phosphatase), aryl sulfatase and cathepsin D. Later 
two additional lysosomal enzymes, a-D-mannosidase and B-glucuronidase 
were determined. 
Acid phosphatase Acid phosphatase activity shows fluctuations 
with respect to time post-injection. There are several peaks of enzyme 
activity (Figure 94) with the two largest being between three and six days 
post-injection and between seven and thirty days. The peak specific 
activity is never twice the control (thirty minutes) and in many cases it 
is less than the control. 
Aryl sulfatase Aryl sulfatase activity also exhibits a cyclic 
pattern, but with peaks between one hour and sixty hours post-injection 
and between seven and thirty days (Figure 95). In this case, the activity 
never drops below the control and is three times the control at fifteen 
days post-injection. 
Figure 94. Effects of Triton WR 1339 injection on acid phosphatase activity. Acid phosphatase 
activity as uMoles Pi/mg protein/hour vs. time post-injection. Line scale equals 
positive standard error of the mean. 
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Figure 95, Effects of Triton WR 1339 injection on aryl sulfatase activity. Aryl sulfatase activity 
as mu moles SO^/mg protein/hour vs, time post-injection. Line scale equals positive 
standard error of the mean. 
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Cathepsin D As with the other two lysosomal marker enzymes, the 
pattern of enzyme activity is cyclic with a major peak between seven and 
thirty days post-injection (Figure 96). The activity never drops below 
the control value and at some points it is seven times the control. 
Because of these fluctuations in specific activities of the three 
enzymes, the assay of two additional lysosomal marker enzymes that were 
reported to have long half-lives ves deemed advisable (D. Opheim, Texas 
A and M University, Bryan, Texas, personal communication, 1976). 
a-D-mannosidase The activity of a-D-mannosidase is linear with 
time post-injection for the first two days and then drops off, but this 
longer half-life enzyme does not demonstrate the cyclic activity seen 
previously (Figure 97). The maximum specific activity is slightly more 
than twice the control. 
B-glucuronidase B-glucuronidase activity increases through two 
days post-injection in a linear fashion and then drops off (Figure 98). 
The highest specific activity is more than three times the control value. 
Endoplasmi c reti culum, microbody and Golgi apparatus markers 
Marker enzymes for each of these membranous organelles were assayed. 
Endoplasmic reti culum Glucose-6-phosphatase was assayed as an 
endoplasmic reticulum marker (Figure 99). The enzyme activity is cyclic 
with the major peak at fifteen days post-injection. The maximum activity 
is three times the control, but at some points the activity is less than 
the control values. 
Microbodies Catalase enzyme activity was studied as an enzymatic 
indicator of microbodies. Catalase activity has several peaks with a 
Figure 96. Effects of Triton WR 1339 injection on cathepsin D activity. Cathepsin D activity as 
u moles tyrosine/mg protein/hour vs. time post-injection. Line scale equals positive 
standard error of the mean. 
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Figure 97. Effect of Triton WR 1339 injection of a a-D-mannosidase 
activity. A-D-mannosidase activity as u moles p-nitro-
phenol liberated/mg protein/hour vs. time post-injection. 
Line scale equals positive standard error of the mean. 
Figure 98. Effect of Triton WR 1339 injection on B-glucuronidase 
activity. B-glucuronidase activity as u moles phenol-
phtalein/mg protein/hour vs. time post-injection. Line 
scale equals positive standard error of the mean. 
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Figure 99. Effects of Triton WR 1339 on glucose-6-phosphatase activity. Glucose-6-phosphatase 
activity as mu moles Pi/mg protein/hour vs. time post-injection. Line scale equals 
positive standard error of the mean. 
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major peak at fifteen days post-injection, but there are at least two 
points, four and six days, where the activity drops below control levels 
(Figure 100). 
Golgi apparatus UDP-N-acetylgalactosyl transferase activity was 
assayed as an enzymatic marker for the Golgi apparatus (Figure 101). The 
activity of this enzyme is cyclical, but there is no peak at fifteen days 
post-injection. The highest activity, twenty-four hours post-injection, 
is five times the control. 
Effect of NaCl and Triton WR 1339 on enzyme activity 
Because of the cyclic nature of the results described in Figures 94-
101 the effects of sham injections of NaCl and of varying concentrations 
of Triton WR 1339 on enzyme activity were checked. 
NaCl (sodium chloride) Sham injections of 0.9% NaCl were injected 
as controls for the effects of the carrier. The result of these injec­
tions on enzyme specific activity was determined for all the enzymes 
except catalase (Figures 102-108). There is no significant change in any 
of these enzyme activities following NaCl treatment with the exception of 
UDP-N-acetylgalactosyl transferase and aryl sulfatase. These latter two 
enzymes do exhibit significant changes in specific activity following 
Triton WR 1339 injection. 
Triton WR 1339 Because of the presumed concentration of Triton WR 
1339 in lysosomes, the effect of varying concentrations of this compound 
on specific activity of lysosomal enzymes was checked. Because of pre­
cipitation problems in the assay systems, only acid phosphatase and 
cathepsin D could be assayed. In both cases there was inhibition of total 
Figure 100. Effects of Triton WR 1339 injection on catalase activity. Catalase activity as units/ 
mg protein/hour vs. time post-injection of Triton WR 1339. Line scale equals positive 
standard error of the mean. 
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Figure 101. Effects of Triton WR 1339 on UDP-N-acetylgalactosyl transferase activity. UDP-N-
acetylgalactosyl transferase activity as mu moles N-acetyllactoseamine/mg protein/ 
hour vs. time post-injection. Line scale equals positive standard error of the 
mean. 
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Figure 102, Effect of injection of 1 ml of 0,9 g NaCI/lOO mg body 
weight on acid phosphatase activity. Line scale equals 
positive standard error of the mean. 
Figure 103. Effect of injection of 1 ml of 0,9 g NaCl/100 mg body 
weight on aryl sulfatase activity. Line scale equals 
positive standard error of the mean. 
Figure 104. Effect of injection of 1 ml of 0,9% NaCl/100 mg body 
weight on cathepsin D activity. Line scale equals 
positive standard error of the mean. 
Figure 105. Effect of injection of 1 ml of 0.9% NaCl/100 mg body 
weight on a-D-mannosidase activity. Line scale equals 
positive standard error of the mean. 
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Figure 106. Effects of injection of 1 ml of 0.9 g NaCl/100 mg body 
weight on B-glucuronidase activity. Line scale equals 
positive standard error of the mean. 
Figure 107. Effects of injection of 1 mo of 0.9 g NaCl/100 mg body 
weight on glucose-6-phosphatase activity. Line scale 
equals positive standard error of the mean. 
Figure 108. Effects of injection of 1 ml of 0.9% NaCl/100 mg body 
weight on UDP-N-acetylgalactosyl transferase activity. 
Line scale equals positive standard error of the mean. 
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enzyme specific activity, up to 44% for acid phosphatase and 41% for aryl 
sulfatase (Figures 109 and 110). 
Figure 109. Effects of varying concentrations of Triton WR 1339 on 
acid phosphatase activity. Line scale equals positive 
standard error of the mean. 
Figure 110. Effects of varying concentrations of Triton WR 1339 on 
cathepsin D activity. Line scale equals positive standard 
error of the mean. 
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DISCUSSION 
Injection of Triton WR 1339 causes several well-defined changes in 
rat hepatocytes. These changes involve the Golgi apparatus, lysosomes and 
microbodies, and, to a lesser extent, the mitochondria. 
Triton WR 1339 
. Triton WR 1339 (polyethylene glycol derivative of polymerized p-tert-
octyl phenol), a nonionic detergent, is a natural lysosomotropic agent 
that accumulates in lysosomes and causes changes in their equilibrium 
densities (224). Recent studies have shown that two fractions, a light 
and a heavy fraction, are present in commercially available Triton WR 1339 
(93,94), but only the heavy fraction is a lysosomotropic agent. As there 
is no direct method for identifying Triton WR 1339 in the ce"*!, (^H)-
Triton WR 1339 has been used to approximate the intracellular location of 
the compound (93,94). Results of such autoradiographic experiments (93, 
94), and other morphological (222,224) and cytochemical (69) studies indi­
cate that the large electron-lucid lysosomes are Triton WR 1339 filled. 
Early studies suggested that Triton WR 1339 entered the cell by one 
of several mechanisms: by direct permeation of the cell membrane (224), 
by a lipoprotein carrier molecule, or by phagocytosis (93,94). The 
present study sheds little light on the mechanism of cellular uptake with 
one notable exception, there is no morphological evidence of endocytosis 
(pinocytosis or phagocytosis) of Triton WR 1339. Although the uncorrob­
orated morphological evidence is not definite, the absence of increased 
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observations of pinocytosis or phagocytosis seems to eliminate endocytosis 
as the mechanism of Triton WR 1339 uptake. Lipoprotein carrier molecules 
have been described in the vascular system that seem to be responsible for 
Triton WR 1339 passage in the circulatory system, but no conclusive evi­
dence has been demonstrated for these carrier molecules in cells (222). 
Permeation of Triton WR 1339 could occur because of its lipid solubility 
characteristics, but thus far only free bases have been observed to 
accumulate in lysosomes by permeation. 
Apparently Triton WR 1339 has some effect on fusion of heterophagic 
and autophagic vacuoles with lysosomes. Davies (47) reported inhibition 
of fusion of trypan blue and albumin containing heterophagic vacuoles with 
secondary lysosomes following Triton WR 1339 injection. In these experi­
ments, the lysosomes were pre-loaded with Triton WR 1339 three days before 
addition of trypan blue or albumin. The results of the present study and 
those of Henning and Plattner (93,94) indicate that Triton WR 1339 enters 
pre-existing lysosomes rather than newly synthesized ones. Although this 
is in contradiction of Davies' work (47), prior injection of Triton WR 
1339 or other lysosomotropic agents could inhibit fusion of heterophagic 
or autophagic vacuoles with lysosomes containing the lysosomotropic agent. 
However, Triton WR 1339 filled lysosomes do fuse with each other (Figures 
78 and 79) and with newly formed primary lysosomes, but they have not been 
observed to fuse with autophagic vacuoles containing myelin figures. This 
observation would support Davies' (47) contentions that Triton WR 1339 
filled lysosomes are inhibited from fusing with heterophatic and auto­
phagic vacuoles. 
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Similarly, Triton WR 1339 has an effect on acid hydrolase specific 
activity. Acid phosphatase and cathepsin D specific activities were 
decreased by at least 40% as indicated in Figures 109 and 110. This in­
hibition occurred as a Triton WR 1339 concentration of 10% (W/V). While 
these concentrations may seem high, they may in fact reflect in vivo 
lysosomal concentrations. Approximately 1%, or .2 g, of the hepatic pro­
tein of a 250 g rat is lysosomal (58). Previous studies have shown that 
50% of the injected Triton WR 1339 is incorporated into hepatic lysosomes 
in the first 24 hours post-injection (222). Therefore, 125 mg of Triton 
WR 1339 would become associated with 1% of the cell volume and 1% of the 
cell protein, the lysosomes, creating W/V and W/W concentrations greater 
than 10% (125 mg Triton WR 1339/200 mg protein). 
In addition, the concentration of Triton WR 1339 inside lysosomes may 
change while Triton WR 1339 accumulates, because during the course of this 
cellular disturbance some cells may die and the released compound may be 
accumulated by other cells. This would have the effect of causing a 
fluctuation in the intracellular concentration of Triton WR 1339 and could 
account for fluctuations in enzyme specific activities. The inhibition of 
lysosomal hydrolase activity could also account for the differences be­
tween these results and those of Wattiaux et al. (224). They reported no 
changes in lysosomal hydrolase specific activities, but a 40% inhibition 
of enzyme activity could indicate a substantial increase in lysosomal 
hydrolase activity during Triton WR 1339 accumulation. Studies with two 
long half-life lysosomal enzymes, B-glucuronidase and a-D-mannosidase, 
indicate that there is continuing synthesis of lysosomal hydrolases, and 
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that the rapid turnover of shorter life lysosomal enzymes could account 
for these fluctuations in specific activity. 
Triton WR 1339 could increase acid hydrolase specific activity by 
several mechanisms. First, as sane of the lysosomal hydrolases are known 
to be tetramers (25,109), Triton WR 1339 could change the ratio of 
monomers to dimers to tetramers and thus alter enzyme activity. Secondly, 
Triton WR 1339 could cause some steric interference, thus inhibiting 
enzyme activity. Third, in addition to inhibiting acid hydrolase activi­
ty, Triton WR 1339 could indirectly stimulate lysosomal hydrolase synthe­
sis. For example, if the inhibition should lower the lysosomal enzyme 
activities below a certain basal level, synthesis could be stimulated. 
Finally, Triton WR 1339 could alter the metabolism of other cellular pro­
teins, thus changing protein concentrations and the specific activities of 
lysosomal hydrolases as compared to total cell protein. It seems likely 
that a combination of increased synthesis, as is suggested by changes in 
Golgi apparatus morphology, and some other factors are involved. 
Autophagy 
Several changes in hepatocyte morphology result from Triton WR 1339 
injection. One of these changes Is an increase in autophagy or the 
sequesterizatlon of recognizable intracellular components inside membrane 
limited vacuoles (autophagic vacuoles). Autophagy during the first few 
hours following injection with Triton WR 1339 has been described by 
Essner and Novikoff (69) who saw numerous mitochondria inside acid phos­
phatase containing structures in hepatocytes. Other studies indicate that 
152 
autophagy is the result of a nonspecific process, probably sub-lethal cell 
damage, rather than a specific process unique to Triton WR 1339. Many 
different compounds will cause similar changes in hepatocytes, including 
sucrose, glucagon, bacitracin, vinblastine and d-tubocurarine, after in­
jection into rats (13,14,63,140,220). Since the chemical nature of these 
compounds is so diverse, stimulation of autophagy is probably a non­
specific reaction of the liver to stress. Glucagon treatment will cause 
the formation of myelin figure lysosomes and autophagic vacuoles in 
hepatocytes that resemble those seen after the first twelve hours post 
Triton WR 1339 injection. In vascular smooth muscle, the ionophoric 
antibiotic X537A can produce the same kind of lysosone formation (197). 
The similarity of these autophagic responses to a variety of conditions, 
in quite different cells, leads one to believe that the effect of Triton 
WR 1339 on cellular autophagy is nonspecific. This is not to say that 
Triton WR 1339 does not cause an increase in au.tophagy, but that autophagy 
is not a unique response to Triton WR 1339. Therefore, autophagy may 
result in the digestion of excess cellular metabolites (sucrose), from 
mobilization of cellular materials under hormonal control (glucagon 
mobilization of glycogen) and as a cellular defense mechanism against 
extracellular compounds (bacitracin, vinblastine, d-tubocurarine and 
X537A). 
Lysosomes 
Lysosomes, as identified by acid phosphatase and aryl sulfatase 
localizations, are the organelles most dramatically altered by Triton WR 
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1339. The changes follow a well defined series of events, including the 
uptake of Triton WR 1339 into lysoscwnes, the increase in size and probably 
number of lysosomes, and the clearance of the Triton WR 1339 from the 
lysosones and cells. 
Many studies have shown that the electron-lucid structures seen in 
hepatocytes following Triton WR 1339 injaction are lysosomes. Morphologi­
cal studies of hepatocytes after Triton WR 1339 injection (69,222,224) and 
autoradiographic studies with {^H)-Triton WR 1339 (93,94) clearly have 
demonstrated that the electron-lucid structures are Triton WR 1339 filled. 
The most evidence is that of Henning and Plattner (93,94) who have shown 
that Triton WR 1339 enters pre-existing lysosomes that have been pre-
labeled with gold chloride. The results of the present study show that 
the Triton WR 1339 filled structures are lysosomes according to the 
presently accepted definition of deDuve (49). The localization of two 
lysosomal enzymes in these structures is unique to this study of liver, 
and definitely establishes them as lysosomes according to the rigorous 
biochemical criteria of deDuve (50). These cytochemical localizations, 
along with the biochemical and sedimentation studies of deDuve and 
Wattiaux (53) and Wattiaux et al. (224), clearly establish the Triton WR 
1339 filled structures as lysosomes according to the following criteria: 
They are sedimentable particles, exhibiting enzyme latency and containing 
at least two lysosomal hydrolases (50). 
Traditionally, acid phosphatase has been used as the cytochemical 
marker for lysosomes, but the lack of specificity of the acid phosphatase 
technique and the large number of other lysosomal hydrolases (more than 40 
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known enzymes) necessitates the use of multiple lysosomal cytochemical 
markers. Although acid phosphatase is the most commonly used lysosomal 
marker, there are several other phosphatases, glucose-6-phosphatase for 
example, that may give false positive localizations. Thus, a second 
lysosomal enzyme localization provides support for identification of 
lysosomes, and meets the criteria of deDuve (50) for identification of 
lysosomes. The present study is the only study of hepatocytes that has 
used the localization of two lysosomal hydrolases as the criteria for the 
identification of lysosomes. Similarly, Hoffstein et al. (104) have used 
acid phosphatase and aryl sulfatase to identify myocardial lysosomes. 
Therefore, localization of at least two enzymes should become the criteri­
on for identification of lysosomes, and will be the standard technique of 
future studies because of the diversity of structures that show acid 
hydrolase activity. 
Localization of two lysosomal hydrolases in the Triton WR 1339 filled 
structures allows the definite identification of these structures as lyso­
somes, and the accumulation of Triton 1339 in these same lysosomes 
suggests attempts by the cell to digest the foreign material. Because of 
the diversity of structures seen in these cells, localization of lysosomal 
hydrolases is essential to the morphological identification of the many 
types of lysosomes. These localizations are limited to a certain extent, 
as all lysosomes may not exhibit all lysosomal hydrolase activities, and 
the identifications are limited to only positively reacting structures. 
For these reasons, the morphology and cytochemistry of lysosomes must be 
interpreted carefully. 
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One function of lysosomes that may be altered by Triton WR 1339 
accumulation is lysosomal fusion. Davies (47) has reported the inhibition 
of fusion of Triton WR 1339 filled lysosomes with heterophagic vacuoles. 
The results of the present study support Davies' hypothesis, although in 
one case (Figure 65), fusing is observed with an autophagic vacuole. Most 
of the fusion is between two Triton WR 1339 filled lysosomes (Figures 78 
and 79). The lysosomes containing mitochondria and myelin figures do not 
exhibit the morphological criteria for Triton WR 1339 accumulation. The 
final determination that fusion of Triton WR 1339 filled lysosomes with 
autophagic vacuoles is impaired must be shown by dynamic autoradiographic 
studies similar to those of Henning and Plattner (93,94) rather than by 
static morphological examination. 
The mechanism of Triton WR 1339 uptake is unclear, but the lysosomal 
changes follow a definite pattern. The first alterations are apparent 
increased numbers of autophagic vacuoles and myelin figures that occur 
during the first twelve hours following Triton WR 1339 injection. These 
early changes also include some Triton WR 1339 filled lysosome formation, 
but these changes are not as obvious as during stage 2 (24 hours through 
8 days). During stage 2, the major morphological changes are increases in 
size and apparent number of Triton WR 1339 filled lysosomes. Evidence of 
Triton WR 1339 filled lysosome formation has been reported earlier (93, 
94,224), but the results of the present study demonstrate the full extent 
of these structural changes. By eight days post-injection the cells are 
filled with large lysosomes that appear to have caused some cellular dis­
integration (Figures 78 and 79). The intracellular distribution of 
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lysosomes changes during this stage as lysosomes move from a pericanalicu­
lar distribution (24 hours) to a more even intracellular distribution (8 
days). The change in distribution is probably due to the increased 
volume occupied by the lysosomes, rather than any physiological change. 
The third change is the clearance of Triton WR 1339 from the cell and thus 
from lysosOTies. There is no direct evidence for the mechanism of clear­
ance, but one observation at 24 hours post-injection (Figure 46) shows the 
apparent fusion of a lysosome with the cell membrane near the bile 
canaliculus, suggesting discharge of lysosomal contents into the bile 
canaliculus. Although the mechanism of clearance is not certain, Triton 
WR 1339 is not obvious in most tissue samples fifteen days after injec­
tion. By sixty days post-injection, the cells appear morphologically 
similar to their controls with the exception of a few remaining Triton WR 
1339 filled lysosomes scattered throughout the cytoplasm. Bruni and 
Porter (37) have shown similar discharge of dense bodies into the bile 
canaliculus, and assumed this was the normal pathway for discharge of 
lysosomal contents. Extracellular release of lysosomal enzymes has been 
described in many physiological processes such as bone resorption, proto­
zoan feeding and in some abnormal conditions such as carbamylcholine 
treatment of chromaffin tissue and experimentally induced arthritis (62). 
Although exocytosis is the suggested mechanism of acid hydrolase release, 
there is no direct evidence of fusion of lysosomes with the plasma mem­
brane in any of these conditions. 
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Golgi Apparatus 
The role of the Golgi apparatus following Triton WR 1339 injection 
seems to be twofold: First, the Golgi apparatus appears to be involved in 
autophagy (Figures 17-20, 37), and second, the Golgi is involved in lyso­
somal enzyme packaging. During the first twelve hours, the mature face of 
the Golgi, the face that gives rise to Golgi vesicles, increases in 
prominence. Essner and Novikoff (69) have described Golgi apparatus in­
volvement in autophagy. These observations support the contention that 
the large vacuoles near the mature face of the Golgi apparatus are auto­
phagic, but they are probably not lysosomes as it has not been possible to 
localize lysosomal marker enzymes in these structures. However, these 
large Golgi vacuoles may be the site of accumulation of Triton WR 1339. 
The second role of the Golgi apparatus in this system is packaging of 
lysosomal enzymes. This process follows the pathway described for the 
packaging of secretory proteins in the exocrine pancrease (109-113). 
During the accumulation of Triton WR 1339, the Golgi apparatus becomes 
elongated or horseshoe shaped. These morphological changes are character­
istic of an actively packaging organelle as seen in pancreas (113-117) and 
anterior pituitary (61). The most active period for Golgi packaging 
occurs during stage 2 of Triton WR 1339 accumulation in hepatocytes. 
During this time period numerous Golgi vesicles are seen near the mature 
face of the Golgi apparatus, and the Golgi is usually close to Triton WR 
1339 filled lysosomes. In some cases, the mature face is in direct 
apposition to a Triton WR 1339 filled lysosome. Although GERL (Golgi 
apparatus, endoplasmic reticulum, lysosome complex) has been described in 
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most tissues (69,153), there is no evidence of GERL involvement in Triton 
WR 1339 filled lysosome formation. There is no evidence of localization 
of lysosomal enzymes in the region of the smooth endoplasmic reticulum 
associated with the mature face of the Golgi apparatus. During state 3, 
the Golgi apparatus returns to a normal configuration, but there is still 
evidence of packaging activity between 15 and 60 days post-injection. It 
is probably due to the replacement of normal components of lysosomes 
(dense bodies) rather than the effect of any remaining Triton WR 1339. 
Finally, by sixty days post-injection the Golgi apparatus returns to a 
configuration that cannot be distinguished morphologically from the con­
trol samples. 
The major unanswered question that concerns the role of the Golgi 
apparatus is the identity of the large presumptive autophagic structures 
seen near the mature face. Present studies indicate that they are not 
lysosomes, but further cytochemical studies with other lysosomal marker 
enzymes would further support this conclusion, and autoradiographic stud­
ies with (^H) Triton WR 1339 would show whether these vacuoles contain 
Triton. However, the best explanation at this time is that thèse struc­
tures are autophagic vacuoles derived fran the Golgi apparatus or endo­
plasmic reticulum. 
Endoplasmic Reticulum 
The only role of the endoplasmic reticulum relative to this study is 
in the formation of autophagic vacuoles during Triton WR 1339 accumula­
tion. With the exception of autophagy where it is involved in sequestering 
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a region of the cytoplasm or an organelle, the endoplasmic reticulum does 
not change during the Triton WR 1339 accumulation process. There is no 
evidence of any change in the amount or distribution of smooth or rough 
endoplasmic reticulum, and there is no conclusive biochemical evidence 
that there are any changes in endoplasmic reticulum marker enzymes. The 
small changes in enzyme activity observed during these experiments may 
simply reflect turnover of membranes due to increased autophagy. 
Microbodies (Peroxisomes) 
Early studies on Triton WR 1339 effects on hepatocytes demonstrated 
changes in lysosomes and peroxisomes. The peroxisome changes, primarily 
increases in catalase activity, were associated with lipid mobilization 
(222). The results of this study support these findings, as catalase 
specific activity remains high throughout most of the Triton WR 1339 
accumulation period and the number of microbodies increases. Two kinds of 
catalase containing structures have been described by Novikoff and 
Novikoff (157). The first is the microbody or peroxisome, a dense cored, 
single membrane-limited structure that shows a positive DAB localization 
for catalase. The second is the microperoxispme, a catalase positive 
element of the smooth endoplasmic reticulum, lacking the dense core of the 
microbody. The catalase positive structures seen in this study are best 
referred to as microbodies and not peroxisomes. According to the defini­
tion of deDuve and Baudhuin (51), microbodies containing catalase are 
morphological entities while peroxisomes are biochemical entities con­
taining catalase and at lease one oxidase (a-acid-amino oxidase or urate 
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oxidase for example). There is no evidence of Triton WR 1339 accumulation 
in microbodies nor fusion of microbodies and Triton WR 1339 filled lyso-
somes. Poole et al. (169) have proposed that lysosomes play a role in the 
turnover of peroxisomes, but there is no morphological evidence of such 
peroxisome degradation by lysosomes in this study. The inhibition of 
fusion of Triton WR 1339 filled lysosomes with peroxisomes or autophagic 
vacuoles containing peroxisomes (47) and therefore inhibition of peroxi­
some degradation could be the explanation for the increase in microbodies. 
Regardless of the reason, there is an increase in catalase activity and in 
catalase positive structures in hepatocytes treated with Triton WR 1339. 
Nucleus and Mitochondria 
There are no obvious changes in the size, number or distribution of 
any other organelles during the Triton WR 1339 accumulation process. The 
nucleus and mitochondria in particular show no changes in morphology or 
distribution, except more mitochondria are observed inside autophagic 
vacuoles as discussed earlier. As the animals were starved prior to the 
experiments, there is little glycogen in the tissue making it difficult to 
determine the effect of Triton WR 1339 on glycogen metabolism. 
Conclusions 
The cellular changes associated with Triton WR 1339 accumulation in 
hepatocytes are twofold, increases in lysosome size and number, and in­
creases in peroxisome number. It appears that Triton WR 1339 accumulation 
in lysosomes simulates storage diseases. There are several parallels 
161 
between the two, in both cases indigestible or slightly digestible materi­
als accumulate in lysosomes. Increased autophagy and myelin figure forma­
tion are characteristic of both conditions. The differences lie in the 
clearance of Triton WR 1339 versus the continued accumulation of material 
in storage diseases. Thé question is whether stored materials would be 
cleared during storage diseases if the supply of substrate was eliminated 
as in this study by the cessation of Triton WR 1339 injection or converse­
ly whether the storage disease would remain if Triton WR 1339 was supplied 
on a continuing basis. There is no answer to the first question, but it 
does seem that the condition would be partially reversed if the supply of 
stored material decreased. The second problem could be answered by serial 
injections of Triton WR 1339 over several weeks. If the large Triton WR 
1339 filled lysosomes persist, there would be evidence that this system 
could serve as a model for storage disease. Another possibility is that 
Triton WR 1339 slows down the autophagic function of lysosomes. If this 
proves to be the case, the system could serve as a model for the study of 
lysosomal activity, and furthermore, if digestive events occur at a re­
duced rate, it would be possible to identify individual steps during the 
process of lysosomal digestion of intracellular and extracellular material. 
The effect of increased lipid mobilization by Triton WR 1339 has not 
been studied, except for general agreement that free fatty acid and 
cholesterol levels increase, and that catalase levels increase (222). The 
reasons are not clear, and there are no other documented cases where lipid 
mobilizing drugs have effects on lysosomes similar to those of Triton WR 
1339. 
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Since there is no reason to distinguish between microbodies and 
peroxisomes in this study, catalase was used as the cytochemical marker 
for these organelles, and, as there is no question as to the identity of 
catalase positive structures, catalase has proven to be an adequate cyto­
chemical marker for the study of lysosome-microbody interaction following 
Triton WR 1339 treatment. Acid phosphatase is the most commonly used 
cytochemical marker for lysosomes, but it is not the optimum lysosomal 
marker- There are a wide variety of phosphatases in most cells. Some of 
these enzymes have acid pH optima, such as the endoplasmic reticular 
enzyme, glucose-6-phosphatase, and all of which can be localized by 
modified Gomori techniques. Also, there is some question as to the 
specificity of acid phosphatase, and therefore, its uniqueness to one 
organelle. However, when this enzyme is used in conjunction with at least 
one other lysosomal marker, most of these reservations can be eliminated. 
Aryl sulfatase was chosen as a second cytochemical marker because of the 
sulfate in detergent, and because of the availability of the substrate. 
Using modifications of the original technique (109), aryl sulfatase local­
izations have proven to be simple and easily repeatable. The choice of a 
cytochemical marker should be based on its relationship to the substrates 
found in the lysosomes being studied. It would be of great value to 
localize some of the acid proteases in the Triton WR 1339 system, but the 
price and availability of these substrates render this unfeasible for most 
laboratories. As these factors change, the possibility that acid prote­
ases can be located in the large autophagic vacuoles near the Golgi 
apparatus and endoplasmic reticulum should be investigated. 
163 
SUMMARY 
The mechanism of Triton WR 1339 accumulation in lysosomes, and 
cellular changes associated with Triton accumulation were investigated in 
rat hepatocytes. Triton WR 1339 was injected intraperitoneally, and 
livers were removed and examined at specific intervals between 0 and 60 
days post-injection. Tissue samples taken at these time intervals were 
examined by electron microscopy for morphological changes. Characteristic 
marker enzymes for lysosomes (acid phosphatase and aryl sulfatase) and 
microbodies (catalase) were localized in tissue samples using cytochemical 
reactions. Morphological distribution of these marker enzymes as judged 
by reaction product deposition was examined by electron microscopy. Spe­
cific activities of marker enzymes for lysosomes (acid phosphatase, aryl 
sulfatase, cathepsin D, B-glucuronidase, and a-D-mannosidase), micro-
bodies (catalase), endoplasmic reticulum (glucose-6-phosphatase) and 
Golgi apparatus (UDP-galactosyl transferase) were assayed using total 
liver homogenates. Changes in the specific activity of these enzymes at 
parallel time intervals were correlated with changes in hepatocyte 
morphology and cytochemically demonstrable marker enzyme distribution. 
Morphological examination demonstrated the accumulation of Triton WR 
1339 in lysosomes during the first eight days post-injection, and the 
clearance of the compound between 15 and 50 days post-injection. There 
was also an increase in autophagy during the first twelve hours following 
injection. Cytochemical localizations of lysosomal marker enzymes 
definitely establish the Triton WR 1339 filled structures as lysosomes. 
In particular, the use of two lysosomal markers is of importance as the 
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lysosomes then meet the biochemical requirements established by deDuve 
(49). Catalase localization indicates that the Triton WR 1339 filled 
structures are not microbodies, and double localizations of aryl sulfatase 
and catalase indicate that lysosomes and microbodies do not fuse under 
these experimental conditions. 
Specific activities of lysosomal enzymes increase during the Triton 
WR 1339 accumulation process, but the activities fluctuate throughout the 
time interval studied. Triton WR 1339 is inhibitory to some lysosomal 
enzymes (acid phosphatase and aryl sulfatase). This inhibition, plus 
possible fluctuations in circulating Triton WR 1339 resulting from death 
of cells filled with Triton, may account for the fluctuations in specific 
activities, and for the previous reports of no change in lysosomal enzyme 
specific activities (216). 
There are still many questions about Triton WR 1339 effects on 
hepatocytes. First, the mechanism of uptake is not known. The speculation 
that endocytosis is involved has been raised, but the results of this 
study raise doubts about this mechanism. This study has revealed no 
evidence of endocytosis during the Triton WR 1339 accumulation process. 
Second, while there is some evidence that lysosomes fuse with the cell 
membrane near the bile canaliculus, there is still some question about the 
fate of Triton WR 1339 in hepatocytes. Third, the effect of Triton WR 
1339 on lysosomal enzyme specific activities needs further investigation. 
Finally, the question of whether this system can serve as a model for the 
study of storage diseases needs to be investigated. In order to simulate 
a storage disease, Triton WR 1339 must remain in the cell for a prolonged 
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period of time, and it must continue to cause the changes seen during the 
first eight days post-injection. Serial injections of Triton WR 1339 over 
sixty or more days followed by removal of the compound should provide a 
suitable model for the study of this phenomena. If the structures seen 
during the first eight days post-injection remain through a long period of 
Triton WR 1339 accumulation, and then disappear, as they do between fif­
teen and sixty days post-injection, this system should serve as a storage 
disease model. 
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